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The C57BL/6 (B6) mouse is the most commonly used inbred strain in biomedical 
research, and has served as the basis for various large-scale genetic and genomic 
projects. Although the parental substrain, C57BL/6J (B6J), originated at The Jackson 
Laboratory, isolated breeding colonies are now maintained at numerous sites. This 
separation has resulted in genetic drift that has led to the emergence of phenotypic 
differences among these colonies. For instance, B6J mice display higher levels of 
voluntary ethanol consumption and increased locomotor responses to 
psychostimulants, relative to C57BL/6N mice (B6N). Initial progress has been made in 
elucidating the genetic bases of these phenotypic differences, as Kumar et al. (2013) 
identified a single nucleotide polymorphism (SNP) in the Cytoplasmic FMR1-interacting 
protein 2 (Cyfip2) gene that underlies the differential locomotor response to cocaine 
exhibited by B6J and B6N mice. The present study compared voluntary ethanol 
consumption, binge-like drinking, and affective behavior during forced abstinence in B6J 
 
 
and C57BL/6NJ (B6NJ) substrains, and when substrain differences were seen, in 
CRISPR-Cas9 engineered lines in which the previously identified substrain-specific 
Cyfip2 SNP was exchanged within the same genetic backgrounds. Results showed that 
B6J consumed significantly greater quantities of ethanol than B6NJ mice and allelic 
variation in Cyfip2 greatly contributed to observed substrain differences in two-bottle 
free-choice ethanol drinking; however, since these differences were completely 
reversed in males, but not females, it’s likely that sex-specific contributions from other 
polymorphisms play a role in moderating these effects. Interestingly, there were no 
significant substrain differences in binge-like drinking or depressive- or anxiety-like 
behaviors during abstinence. Overall, while B6J and B6NJ mice displayed dramatic 
differences in voluntary ethanol consumption, which were dependent in part on an 
identified cocaine-relevant SNP in Cyfip2, no substrain differences were seen in binge-
like drinking or affective behavior during abstinence. These results imply that primarily 
non-overlapping gene sets underlie these specific ethanol-related phenotypes.
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CHAPTER 1 
INTRODUCTION 
 Ethanol is a common part of the human diet. Produced by the fermentation of 
sugars by yeast, ethanol is one of the oldest known psychoactive drugs. Although 
generally consumed in Western countries, the quantity and frequency of ethanol 
consumption varies greatly between populations and among individuals (Gilmore et al., 
2016). For example, men typically consume more ethanol than women and individuals 
living in industrialized countries drink more than those in non-industrialized countries 
(Rehm et al., 2009). Unfortunately, ethanol misuse accounts for approximately 3.3 
million deaths worldwide (World Health Organization, 2014), and, in the United States, 
excessive ethanol consumption is the third leading cause of death, accounting for 
roughly 88,000 deaths per year (Centers for Disease Control and Prevention, 2014). 
 By certain accounts, ethanol has greater overall harmful effects (i.e., harm to 
oneself, friends, family, and/or society) than any other drug, most notably including 
heroin, methamphetamine, and cocaine (Nutt, King, & Phillips, 2010). This is likely due, 
in part, to the complex pharmacological profile of ethanol, which primarily exerts 
opposing effects on the major excitatory and inhibitory neurotransmitter systems in the 
brain, glutamate and gamma-aminobutyric acid (GABA), respectively (Tabakoff & 
Hoffman, 2013; Vengeliene, Bilbao, Molander, & Spanagel, 2008). Since ethanol 
exhibits a general pattern of pharmacodynamic tolerance, as with other drugs of abuse, 
sustained high levels of intake can lead to dependence and consequent development of 
both pathophysiology and psychopathology. 
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 There appears to be a substantial genetic contribution for development of Alcohol 
Use Disorder (AUD; American Psychological Association, 2013), as twin studies 
suggest that 50-60% of individual differences in risk are heritable (Enoch & Goldman, 
2001). In turn, vulnerability to pathological drinking is likely mediated by complex 
interactions between genes and environment, as the degree of genetic influence on 
drinking outcomes appears to vary in different populations and under different 
environmental circumstances (Young-Wolff, Enoch, & Prescott, 2011). Thus, in order to 
gain a better understanding of the underlying factors involved, researchers have 
developed and employed 1) different genetic diversity approaches for gene discovery, 
and 2) animal models of various ethanol-related behaviors. 
1.1. Genetic Diversity Approaches in Mice  
1.1.1. Selectively-Bred Lines and the Development of Inbred Strains 
 The various genetically defined populations of laboratory mice currently available 
for scientific research were derived from animals supplied to early mouse geneticists by 
hobbyist breeders. Miss Abbie Lathrop provided a critical link between the mouse 
hobbyist community and early American mouse geneticists. Lathrop was a retired 
school teacher who began to breed mice in the early 1900s, and provided early 
geneticists – most notably, William Castle, Director of the Bussey Institute for Applied 
Biology of Harvard University – with a continual source of different mouse varieties for 
experimental purposes (Morse, 1978). Researchers were aware of the previous artificial 
selection pressures exerted on these mouse populations, as Chinese and Japanese 
historical records indicated that many individuals bred, collected, and traded mice based 
on unusual coat appearance and behavior (Sage, 1981). In turn, researchers 
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acknowledged the value of exploiting artificial selection principles to produce laboratory 
mice that exhibited specific disease-related phenotypes, an important methodology that 
is still widely utilized in current biomedical science. 
 Since there are noticeable differences in most phenotypes among genetically 
heterogenous mice, such a population can be screened for variability in a particular 
phenotype and separated into distinct breeding lines based on “high” or “low” 
phenotypic expression. Continued breeding of animals demonstrating the same extreme 
phenotype will eventually result in the emergence of two stable, bidirectionally 
selectively-bred lines. In feasible circumstances, replicate and control lines are also 
produced in order to yield greater assurance that the results of particular selective-
breeding efforts are primarily due to gene frequency variations at trait-relevant loci 
rather than consequences of genetic drift (Crabbe, Phillips, & Belknap, 2010). Although 
many early geneticists were focused on studying disease states resulting from single 
gene mutations, it was increasingly realized that many phenotypes of biomedical 
significance are quantitative in nature, and are affected by multiple genes as well as 
environmental factors (Broman, 2001). Therefore, selectively-bred mouse lines were 
acknowledged as a powerful animal model since they allow for the possibility that 
multiple genes will contribute to the divergent phenotype and permit researchers to 
directionally manipulate the presence or absence of a particular trait so that specific 
aspects of a disease state can be achieved by design (Falconer & Mackay, 1996). 
Additionally, examining two bidirectional selectively-bred lines for a phenotype distinct 
from the selection phenotype can reveal whether overlapping gene sets contribute to 
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multiple traits. This approach is extremely valuable, as it enables discovery of 
genetically correlated traits (Crabbe, Phillips, Kosobud, & Belknap, 1990). 
 Arguably the most significant contribution of the Castle group at Harvard was the 
realization that a complementary approach to selective breeding, involving the 
development of isogenic lines of mice, termed inbred strains, was needed. Although the 
original rationale for their development was to help reveal the genetic basis for various 
forms of cancer (Morse, 1978), these inbred strains have played a vital role in all 
domains of biomedical research. 
 An inbred strain is established through at least 20 consecutive generations of 
sibling matings, at which point approximately 98.6% of all loci will be homozygous 
(Davisson, 1996). Indeed, many of today’s common inbred strains have been inbred for 
over 150 generations, rendering these animals homozygous at essentially all loci, such 
that each individual animal within a particular strain can plausibly be treated as a clone 
(Beck et al., 2000). In fact, some of the inbred strain families most commonly used in 
mouse genetics today, including C57BL/6 (B6) and C57BL/10 (B10), are derived directly 
from the mice Lathrop sold to Castle (Morse, 1978). 
 The major strength of inbred strains lies in their genetic similarity, which produce 
greater reproducibility of experimental findings while also allowing the testing of fewer 
animals (compared to outbred animals) without sacrificing statistical power. In addition, 
if a considerable number of inbred strains are tested for multiple traits, strain means can 
be used to assess genetic correlation among traits. Although labor intensive, tests of 
genetic correlation become increasingly powerful the more inbred strains are included. 
However, since classical inbred strains are derived from a limited population (Lathrop 
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stocks), they are somewhat restricted in their power as a tool for discovering the 
underlying genetic variation modulating a complex trait (A. Roberts, Pardo-Manuel de 
Villena, Wang, McMillan, & Threadgill, 2007). Therefore, to expand the power of the 
approach, researchers have used inbred strains as the foundation for a wide variety of 
experimental crosses, heterogeneous and mutant stocks, and other research 
populations created for the sole purpose of examining the underlying genetic influences 
of complex traits (i.e., “mapping populations”; Chesler, 2014). 
1.1.2. Quantitative Trait Loci Analysis and Traditional Experimental Crosses 
 Quantitative Trait Loci (QTL) analysis is a statistical method that links phenotypic 
data (trait measurements) and genotypic data (typically molecular markers) in an 
attempt to identify genetic loci (each of which likely encompasses many genes) that 
have significant effects on a phenotype of interest (Falconer & Mackay, 1996). 
Specifically, knowledge of the number, locations, effects, and identities of QTLs can 
lead to identification of specific genes (Zeng, 1994). 
 In order to perform a QTL analysis, researchers must first select two or more 
strains of organisms that differ genetically with regard to a trait of interest as well as 
genetic markers that distinguish between these parental strains. Ideally, several types of 
genetic markers are utilized, including single-nucleotide polymorphisms (SNPs), 
microsatellites, restriction fragment length polymorphisms, and transposable 
element positions (Vignal, Milan, SanCristobal, & Eggen, 2002). Additionally, for 
polygenic traits, parental strains are not required to differ in the phenotype of interest; 
more importantly, they must possess different alleles, which are then shuffled 
by recombination in the derived population to produce a range of phenotypic values. 
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 The two most common breeding schemes used for QTL analysis are referred to 
as a backcross and an intercross (Silver, 1995). In both strategies, parental strains are 
first crossed to obtain the F1 generation, who receive one copy of each chromosome 
from each parent. Thus, F1 animals are isogenic and heterozygous at all loci that are 
polymorphic in the parental strains. In a backcross, the F1 generation is subsequently 
backcrossed to one of the parental strains to produce a segregating N2 population. In 
contrast, an intercross involves crossing pairs of F1 mice to obtain a F2 generation, 
such that the F2 progeny receive a recombinant chromosome from each parent. 
Therefore, at any autosomal locus, F2 progeny can possess either a “AA”, “AB”, or “BB” 
genotype. Thus, an intercross can detect a QTL regardless of which parental allele is 
dominant, while a backcross can only detect a QTL if the backcrossed parental allele is 
non-dominant (Kostrzewa & Kas, 2014). In either case, animals from all three 
generations are phenotyped to ensure a proper progression in phenotypic variation, as 
the F2 generation should show greater phenotypic variation due to their increased 
genetic variation (Broman, 2001). 
1.1.3. Recombinant Inbred Strains, Collaborative Cross, and Diversity Outbred Mice 
 As aforementioned, siblings in the F2 generation are no longer identical because 
of the segregation of the respective alleles from the heterozygous F1 parents. For a 
single pair of homologs, each of the F2 animals will have a unique genotype with some 
loci homozygous for either the mother or father’s contributing allele, or heterozygous 
with both alleles. At this point, several pairs of F2 animals can be chosen at random to 
serve as the founders for a set of new “recombinant inbred” (RI) strains. Offspring from 
each F2 founder pair are then chosen randomly for sibling mating in order to produce 
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the next generation. This process is repeated for 20 consecutive generations and 
results in a set of new RI strains (Silver, 1995).  
 Interestingly, like classical inbred strains, RI strains are fixed to homozygosity at 
the vast majority of loci (Crabbe, Janowsky, Young, & Rigter, 1980). Therefore, the 
genomic composition of each RI strain can be maintained indefinitely by continued 
sibling mating. However, the “gene pool” of a set of RI strains, no matter how large the 
set, is also greatly restricted. Thus, since each RI strain is developed from only two 
inbred (and thus homozygous) parental strains, there are only two possible alleles (at 
most) that can be present at any given genetic locus (Broman, 2005). Further, since 
there is only a limited number of opportunities for recombination to occur between the 
two sets of progenitor chromosomes before inbreeding to homozygosity, complete 
homogenization of the genome is extremely unlikely (Winkler, Jensen, Cooper, Podlich, 
& Smith, 2003). Theoretically, particular genomic regions can already be fixed at the 
onset of the F2 crosses, and with each subsequent generation, additional genomic 
regions will become fixed in an allelic state reflecting contributions from the mother or 
father, respectively. After 20 consecutive generations of inbreeding, each RI strain will 
be represented by a group of animals that will all carry the same genomic components, 
but with random pieces from each of the two progenitors. Although paradoxical, the 
utility of RI strains lies in this homozygosity, as every RI strain has different 
recombination sites distributed randomly throughout its genome (Broman, 2005). A set 
of RI strains can be used to obtain information on linkage and map distances in a 
manner analogous to the F2 progeny from a traditional experimental cross (Crabbe et 
al., 1980). The major difference is the particular genotype present within each RI strain 
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can be indefinitely sustained, providing no limit to the number of loci that can be 
analyzed within an RI strain (Chesler et al., 2008). 
 Further advancements in molecular biology and computing have led to the 
emergence of systems genetics, a more recent perspective of genetic analysis aimed at 
better understanding how genes function and interact in the context of their respective 
biochemical pathways. In 2004, the Collaborative Cross (CC) was created to support 
systems genetics analysis. The CC population consisted of a thousand RI strains 
produced by an eight-way funnel breeding design involving a total of eight genetically 
diverse founder strains: five classical inbred strains (A/J, C57BL/6J, 129S1/SvImJ, 
NOD/ShiLtJ, NZO/HiLtJ) and three wild-derived strains (CAST/EiJ, PWK/PhJ, and 
WSB/EiJ) (Churchill et al., 2004). This specific breeding paradigm results in the 
genomes of each strain having equal contributions from each founder strain, and the 
accumulated recombinations being independent between strains (Chesler, 2014). 
Although similar in premise to existing RI strain panels, the CC is able to capture 
considerably more genetic diversity and provide sufficient power and resolution for 
genetic dissection of polygenic traits and construction of systems genetic networks. This 
is due to the inclusion of multiple progenitor strains, especially the utilization of wild-
derived strains, in the CC, in contrast to RI strain panels that originate from only two 
inbred strains, resulting in limited statistical power and ability to capture allelic diversity 
(Chesler et al., 2008). Indeed, analysis of the allelic variation in inbred strains 
demonstrates that the eight founder strains of the CC capture approximately 90% of the 
known allelic diversity across all 1 Mb intervals spanning the entire mouse genome (A. 
Roberts et al., 2007). Overall, while the properties of the CC (high genetic diversity, 
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statistical power, and large number of independent recombinations) illustrate its 
potential as a systems genetics tool, continued efforts will determine whether the CC 
indeed confers a considerable improvement over the mapping resolution possible in 
traditional mouse crossing paradigms. 
 Although the CC has demonstrated significant success at producing more 
genetically diverse mouse populations, there will always be a degree of restricted allelic 
diversity since these heterogenous populations are still largely derived from classical 
inbred strains. This overall breeding history has led to a greatly limited range of 
behavioral variation, resulting in the introduction of false positive correlations among 
behavioral phenotypes, as parallel effects of genetic linkage are mistaken for pleiotropic 
actions of the same polymorphisms (Chesler, 2014). Therefore, in 2009, a 
complementary approach to the CC, termed the Diversity Outbred (DO), was initiated. 
This newer method was developed to employ a novel outbreeding strategy that 
maintains a balanced mixture of the founder genomes and avoids allelic loss and 
inbreeding (Churchill, Gatti, Munger, & Svenson, 2012; Svenson et al., 2012). The DO 
population is derived from CC mice at various stages of inbreeding, intercrossed in a 
semi-randomized manner. In this intercross strategy, sibling or first cousin mating is 
specifically avoided; thus, recombinations are randomized and founder haplotypes are 
distributed throughout the population (Chesler, 2014). This is the innovative aspect of 
the DO, as each individual mouse is genetically unique and possesses a high level of 
allelic heterozygosity. While the CC strains are being inbred to produce stable clones, 
the DO are strictly being maintained as an outbred stock; thus, the DO population 
effectively provides an unlimited source of novel allelic combinations, analogous to 
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human genetics (Bogue, Churchill, & Chesler, 2015). However, the drawback of the DO 
is that the genetically unique individual genomes are not reproducible, as in the CC. 
Nevertheless, combinations of genetic loci that are discovered in the DO mice can be 
replicated in CC strains (Gatti et al., 2014). To this end, tools like the CC and DO should 
allow researchers to better resolve QTL intervals and identify underlying genes for a 
diverse set of phenotypes (Logan et al., 2013). 
1.1.4. Inbred Substrains 
 Following the emergence of inbred mouse strains, researchers from many 
biological disciplines were eager to integrate these animal models into their research. 
Demand for such mice increased so dramatically that some research institutions 
realized the financial prospect of maintaining inbred mouse strains for sale to the 
greater scientific community. Among the first to capitalize on this opportunity was The 
Jackson Laboratory (JAX), founded by C.C. Little in 1929, which began sales of inbred 
mice in 1933 (Morse, 1978). Little had started deriving various inbred strains at Harvard 
by 1909, with one of more popular inbred strains, C57BL/6 (B6), having been derived in 
1921. To distinguish the B6 colony specific to JAX, the additional nomenclature of “J”, 
for JAX, was added to indicate the colony maintenance site. This seemingly insignificant 
nomenclature change would prove to be an important identifier in the future, as 
separate breeding colonies of the same inbred strains began to be maintained at 
several different locations, leading to the eventual unplanned emergence of numerous 
B6 substrains (Bryant, 2011). 
 In 1951, JAX sent C57BL/6J (B6J) mice to the National Institutes of Health (NIH), 
which they used to establish their own colony. However, colony separation leads to 
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genetic divergence over time, as genetic drift will occur. Therefore, every time a new 
colony is maintained separately from an existing colony for 20 or more generations, it 
can become a genotypically distinct new substrain (Bailey, 1982). In turn, the B6J 
mouse colony at NIH subsequently became known as C57BL/6N (B6N) mice, formally 
recognizing B6J and B6N as distinct substrains. 
 To date, B6J and B6N mice have been inbred separately for over 5 decades and 
220 generations (Mulligan et al., 2008; Simon et al., 2013). Further, over time, separate 
colonies of B6N have been established at several other breeding sites – Charles River 
Laboratories in 1974 (C57BL/6NCrl; B6NCrl), Taconic Biosciences in 1991 
(C57BL/6NTac; B6NTac), and back to JAX in 2005 (C57BL/6NJ; B6NJ). Thus, it is not 
surprising that significant genotypic and phenotypic differences have been observed 
among the various B6 substrains, with most work specifically comparing B6J (the 
parental substrain) to B6N and its associated derivatives (B6NCrl, B6NTac, B6NJ) 
(Bryant et al., 2008; Matsuo et al., 2010; Mekada et al., 2009). Notably, different B6 
substrains have been used in various large-scale genomics initiatives. While B6J mice 
were used in the original Mouse Genome Sequencing Consortium (Church et al., 2009; 
Waterston et al., 2002), B6N mice are being used in the various projects associated 
with the International Knockout Mouse Consortium (Austin et al., 2004; Pettitt et al., 
2009; Skarnes et al., 2011). It is critical, therefore, that researchers take specific notice 
of potential differences between B6 substrains when planning experiments and/or 
comparing data across studies. On the positive side, however, the over 20 commercially 
available B6 substrains provide a potentially powerful genetic resource for identifying 
previously unknown genes and alleles controlling complex traits (Kumar et al., 2013). 
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1.1.5. Summary 
 As discussed, mouse geneticists have developed a spectrum of potential 
mapping populations with the purpose of elucidating the genetic basis 
of quantitative traits, including complex behaviors thought to model aspects of disease 
states. The major benefits of utilizing a genetically complex population such as the CC 
and DO are that (1) any positive findings have a relatively high likelihood of being 
generalizable, (2) genetically heterogenous mice typically exhibit high phenotypic 
variation, and (3) QTLs may be mapped with comparatively high resolution. On the 
other hand, this approach is likely to identify multiple significant QTLs, each with small 
effect sizes, making it difficult to identify specific influential variants within these QTL 
intervals. In contrast, while the use of genetically simpler populations, such as traditional 
F2 crosses of inbred strains, RI strains, and/or distinct inbred substrains, provides 
limited generalizability of findings and more restricted phenotypic variation, this 
approach increases the probability of finding a smaller number of significant QTLs, each 
with comparatively larger effect sizes, and of identifying specific influential variants 
within a given QTL interval. Although efforts in gene discovery and functional 
identification have progressed rapidly during the past 30 years, approximately 70% of 
current neuroscience literature concerns approximately 5% of known genes (Pandey, 
Lu, Wang, Homayouni, & Williams, 2014). Thus, appropriate integration of results 
derived from different genetic diversity approaches will be essential to avoiding 
stagnation in the field of neurogenetics. 
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1.2. Animal Genetic Models of Ethanol-Related Behaviors 
 AUD is a complex, chronic disorder characterized by a collection of clinically-
defined behaviors that are influenced by numerous genetic and environmental factors. 
The core symptoms of AUD include the presence of both metabolic and functional 
tolerance to ethanol, uncontrollable compulsions to seek and consume ethanol, 
emergence of a negative affective state (e.g. irritability, anxiety, depression, etc.) that 
defines a withdrawal syndrome when ethanol consumption is terminated, and intense 
cravings to consume ethanol during abstinence (Mason, 2017). Although creation of a 
single animal model that encapsulates each of these defining criteria would be ideal, the 
inherent complexity of this behavioral profile renders this task extremely unlikely. For 
instance, a prototypical animal model of AUD would exhibit excessive voluntary ethanol 
intake that 1) is based on positive reinforcement of ethanol’s pharmacological effects, 
rather than its caloric value or preference for sweet taste (Bachmanov et al., 2003; 
Spanagel, 2000), 2) leads to patterns of uncontrollable consumption (H. C. Becker & 
Ron, 2014), 3) produces pharmacologically significant levels of blood ethanol 
concentrations (BECs) which result in metabolic and functional tolerance (Kalant, 
LeBlanc, & Gibbins, 1971), and 4) results in the emergence of negative affective state 
(Heilig, Egli, Crabbe, & Becker, 2010; Kliethermes, 2005) and craving behaviors with 
periods of relapse during abstinence due to negative reinforcement (Rodd, Bell, Sable, 
Murphy, & McBride, 2004). Thus, researchers have attempted to develop protocols that 
aim to model a specific component(s) of AUD while conserving face and predictive 
validity. 
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1.2.1. Two-Bottle Free-Choice Drinking 
 Ethanol intake is commonly assessed in rodents by providing them with 
continuous access to an ethanol solution and plain water over the course of several 
days or even weeks. This paradigm, termed two-bottle free-choice or “ethanol 
preference drinking”, provides a measure of voluntary oral ethanol consumption, as the 
animal is not forced to drink from the ethanol bottle to alleviate hunger (food is available 
ad libitum) or thirst (Leeman et al., 2010; Tabakoff & Hoffman, 2000). However, 
researchers often question whether the display of substantial ethanol intake in this 
paradigm is necessarily reflective of significant ethanol-reinforced behavior (A. S. Green 
& Grahame, 2008). For instance, even seemingly insignificant factors, such as position 
and total number of solutions available, have been shown to notably influence results. 
Previous work has demonstrated that rodents typically consume more fluid from bottles 
located closer to the food hopper (Bachmanov, Reed, Beauchamp, & Tordoff, 2002), 
while simultaneous access to additional concentrations of ethanol solution drastically 
increases overall ethanol intake (Tordoff & Bachmanov, 2003). Furthermore, the total 
number of access days or weeks plays an important role in overall ethanol preference, 
as “ethanol-avoiding” rodents generally exhibit decreased preference across time, 
whereas “ethanol-preferring” rodents, for the most part, show increased preference 
(Blizard, Vandenbergh, Lionikas, & McClearn, 2008). Sensory modalities, such as taste 
and olfaction, also play an important role in the oral consumption of ethanol 
(Bachmanov et al., 2003). Like humans, rodents can detect the sweet and bitter 
properties (Kiefer & Lawrence, 1988; Kiefer & Mahadevan, 1993) and odor volatiles 
(Kiefer & Morrow, 1991) of ethanol. A positive correlation between ethanol and sweet 
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taste has been characterized extensively in mice (Bachmanov, Reed, Tordoff, Price, & 
Beauchamp, 1996; Blednov et al., 2008), rats (Dess, Badia-Elder, Thiele, Kiefer, & 
Blizard, 1998; Gosnell & Krahn, 1992), and even human alcohol-dependent patients 
(Kampov-Polevoy, Garbutt, & Janowsky, 1999; 1997). 
 Many inbred strains of mice avoid a 10% ethanol solution (i.e., exhibit an ethanol 
preference of less than 50%) unless it is masked by a sweetening agent, such as 
sucrose or saccharin (Belknap, Crabbe, & Young, 1993). Such findings imply that, 
during continuous two-bottle free-choice access, animals who demonstrate low 
voluntary oral ethanol intake likely never achieve “pharmacologically relevant” blood 
ethanol levels sufficient to experience the positive reinforcement properties of ethanol. A 
previous analysis found that the degree of ethanol preference exhibited under 
continuous two-bottle free-choice conditions corresponded with the relative strength of 
the reinforcing effects of ethanol as measured by operant oral self-administration (OSA) 
and conditioned taste aversion (CTA), but not conditioned place preference (CPP) 
procedures (A. S. Green & Grahame, 2008). Interestingly, Grahame & Cunningham 
(1997) examined operant intravenous self-administration (IVSA) of ethanol in an attempt 
to circumvent the requirement that the animal drinks an ethanol solution to experience 
its postingestive effects. In other words, through IVSA, the reinforcing effects of ethanol 
depend solely on its postingestive (i.e., pharmacological effects), rather than 
preingestive (i.e., taste and smell), consequences. Although this approach is most 
commonly utilized to examine the reinforcing properties of psychostimulant drugs, such 
as cocaine (J. E. Smith et al., 2004), it perhaps has the potential to resolve previous 
interpretative complications associated with voluntary oral consumption. For example, 
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while DBA/2J (D2J) mice voluntarily orally consume such minute amounts of ethanol 
that they likely never encounter its pharmacological effects (Belknap et al., 1993; 
Belknap, Coleman, & Foster, 1978), they intravenously self-administer ethanol at a rate 
similar to other inbred strains of mice that consistently show far greater ethanol intake 
during two-bottle free-choice conditions (Grahame & Cunningham, 1997). These data 
suggest that, unlike findings using OSA and CTA, IVSA (and CPP) appear to not be 
related to continuous two-bottle free-choice drinking (A. S. Green & Grahame, 2008). 
Nevertheless, additional IVSA studies are needed in order to draw more concrete 
relationships among these differing paradigms of voluntary consumption. 
 While much has been learned from the study of two-bottle free-choice ethanol 
drinking, animals tested in this protocol rarely, if ever, generate high enough intake to 
produce sustained intoxication or the induction of dependence-related phenomena. 
Thus, two-bottle free-choice ethanol drinking is probably best viewed as a model of non-
pathological (“controlled”) ethanol intake, influenced by a variety of factors including 
ethanol reward, taste and smell, caloric value, and genetic background. 
 Due to its high-throughput nature, there is accumulating gene expression data on 
ethanol preference drinking (Crabbe et al., 2010; McBride et al., 2010; Mulligan et al., 
2006; Tabakoff et al., 2009); however, such studies will not be mentioned in detail for 
several reasons. First, since most behavioral traits are influenced by many genes, an 
individual gene likely exerts a minor overall effect on the trait. Likewise, ‘‘ethanol 
preference drinking’’ does not appear to be mediated by a single neurotransmitter 
system nor result from changes in a single, isolated brain structure or neural circuit. 
Second, to this end, the isolated use of advanced techniques available for single gene 
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manipulation (e.g., knockouts, transgenics, etc.) are unable to reveal potential 
significant gene sets for a trait of interest. Nonetheless, about 100 genes have been 
targeted, a quarter of which have been tested for their respective influence on ethanol 
preference drinking. The current data indicates that approximately a third of these 
genes appear to produce either a modest increase, decrease, or no significant effect in 
ethanol preference drinking (Crabbe et al., 2010; Crabbe, Phillips, Harris, Arends, & 
Koob, 2006). 
 On the other hand, the two-bottle free-choice paradigm is the most commonly 
assayed ethanol-related phenotype in genetic discovery efforts. Most notably, there 
have been a plethora of rat and mouse lines selectively-bred for either high or low 
ethanol preference (usually a 10% v/v solution) relative to plain water under continuous 
two-bottle free-choice access. The four most prominent bidirectional selectively-bred rat 
lines include: 1) the “Alko Alcohol” (AA) and “Alko Nonalcohol” (ANA) lines (Eriksson, 
1968), 2) the “alcohol-preferring” (P) and “nonalcohol preferring” (NP) lines (McBride, 
Rodd, Bell, Lumeng, & Li, 2014), 3) the “high alcohol drinking” (HAD) and “low alcohol 
drinking” (LAD) lines (McBride et al., 2014), and 4) the “Sardinian alcohol preferring” 
(sP) and “Sardinian non-alcohol preferring” (sNP) lines (Colombo et al., 1997). Each of 
these ethanol-preferring lines voluntarily consume greater than 5 g/kg/day (Colombo et 
al., 1997; McKinzie et al., 1998; Murphy et al., 2002; Ritz, George, deFiebre, & Meisch, 
1986), which is roughly equivalent to 9-14 standard alcoholic drinks per day (Murphy et 
al., 2002; Rodd et al., 2004). Mice have also been selectively-bred for either high or low 
ethanol preference drinking, with the most popular divergent lines termed “high alcohol 
preferring” (HAP) and “low alcohol preferring” (LAP) (Grahame, Li, & Lumeng, 1999). 
18 
 
Interestingly, daily ethanol intake levels of HAP lines were surprisingly modest, in 
contrast to the aforementioned selected rat lines. Therefore, researchers intercrossed 
two of the high drinking HAP lines in order to produce a “crossed HAP” (cHAP) line 
(Oberlin, Best, Matson, Henderson, & Grahame, 2011), which consumed significantly 
greater quantities of ethanol and achieved blood ethanol levels near 200 mg/dL (Matson 
& Grahame, 2013). 
 Variations in two-bottle free-choice ethanol drinking among inbred strains have 
consistently been established through inbred strain panel studies (McClearn & Rodgers, 
1959; Belknap et al., 1993; Yoneyama, Crabbe, Ford, Murillo, & Finn, 2008). In the most 
recent investigation, Yoneyama et al. (2008) examined 22 inbred strains under 
continuous two-bottle free-choice access to varying ethanol concentrations presented in 
a serial manner. Consistent with previous panel studies, B6J mice exhibited among the 
highest daily ethanol consumption (>10 g/kg/day) while D2J mice consumed among the 
lowest (<2 g/kg/day). In fact, these strain differences have remained extraordinarily 
stable over time and across laboratories, as analysis of these inbred panel studies 
revealed strain mean correlations between .74 and .98 (Crabbe, 2014; Wahlsten, 
Bachmanov, Finn, & Crabbe, 2006). 
 Moreover, B6J and D2J inbred strains have become the foundation for numerous 
QTL mapping efforts for two-bottle free-choice ethanol drinking. An influential meta-
analysis of experimental crosses involving B6J and D2J mice suggested the presence 
of significant QTLs on chromosomes 2, 3, 4, and 9 (Belknap & Atkins, 2001). 
Subsequently, additional supporting evidence emerged and verified the likelihood of 
QTLs specifically on chromosomes 2 (Fehr et al., 2005) and 9 (Hitzemann et al., 2004). 
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As QTL confirmation efforts are ongoing, this evidence cannot be interpreted as 
definitive; but, notable potential gene candidates include syntaxin binding protein 1 
(Stxbp1) on chromosome 2 and sodium channel, type IV, (Scn4b) on chromosome 9 
(Crabbe, 2014). 
 Of particular interest to this dissertation, B6 substrains have been found to 
display consistent differences in ethanol preference drinking (Blum, Briggs, DeLallo, 
Elston, & Ochoa, 1982; Mulligan et al., 2008; Poley, 1972; Ramachandra, Phuc, Franco, 
& Gonzales, 2007; Whitney & Horowitz, 1978). Specifically, B6J mice have reliably 
exhibited higher voluntary ethanol consumption and preference compared to several 
B6N derivatives; however, B6J and B6NJ mice have not been compared previously. To 
this end, Experiment 1 of this dissertation examined voluntary ethanol consumption and 
preference in B6J and B6NJ mice as well as in CRISPR-engineered mice designed to 
identify specific genetic contributions to these substrain differences. 
1.2.2. Alcohol Deprivation Effect 
 Since continuous free-choice ethanol access does not produce “excessive” 
intake, researchers sought to develop a protocol to initiate binge-like drinking in rodents. 
Early observations found that introducing a period of forced ethanol deprivation could 
result in a subsequent transient increase in voluntary intake (Crabbe, Spence, Brown, & 
Metten, 2011). Specifically, rats with a significant prior history of continuous free-choice 
ethanol drinking exhibit a brief, notable increase in ethanol intake following one week of 
deprivation (Sinclair & Senter, 1967; 1968). This phenomenon, now termed the “alcohol 
deprivation effect” (ADE), has since been further characterized in rats (Henniger, 
Spanagel, Wigger, Landgraf, & Hölter, 2002; Rodd-Henricks et al., 2001; 2000; Serra et 
20 
 
al., 2003; Spanagel & Hölter, 1999; Vengeliene et al., 2003), mice (Ford et al., 2011; 
Khisti, Wolstenholme, Shelton, & Miles, 2006; Melendez, Middaugh, & Kalivas, 2006; 
Salimov, Salimova, Shvets, & Maisky, 2000), and even non-human primates (Sinclair, 
1972; Kornet et al., 1990). Additionally, the ADE has been observed using limited-
access OSA procedures in both rats and mice (Heyser, Schulteis, & Koob, 1997; Hölter, 
Landgraf, Zieglgänsberger, & Spanagel, 1997; Sparta et al., 2009), suggesting that the 
ADE represents “motivated” ethanol consumption. 
 Various factors appear to modulate the ADE, including the number of ethanol 
solutions available and both the duration of initial ethanol access and the deprivation 
interval (Breese et al., 2005; Crabbe et al., 2011). Indeed, manifestation of the ADE is 
more robust and enduring when rats are given concomitant access to two additional 
ethanol solutions along with water (Rodd-Henricks et al., 2001). Moreover, the minimum 
initial ethanol access period necessary for subsequent emergence of the ADE is about 
three weeks, though most studies typically use at least six weeks (Rodd et al., 2004; 
Vengeliene, Bilbao, & Spanagel, 2014). In terms of necessary deprivation duration, the 
ADE may be observed following relatively short periods (hours to days; Spanagel & 
Hölter, 1999), or longer periods (weeks to months; Hölter et al., 1997). Nonetheless, the 
observed increase in ethanol intake after either short or long periods of deprivation is 
typically brief, with intake normally returning to pre-deprivation levels within 48 hours. 
 Interestingly, the ADE may be amplified, in terms of both magnitude and 
duration, by repeated cycles of intermittent ethanol access (Rodd et al., 2004; 2003; 
Spanagel, 2000). This modified paradigm, termed the “repeated alcohol deprivation 
effect” (RADE), is especially thought to be a valid animal model of pathological drinking 
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since it mimics the cyclical nature of abstinence and relapse periods experienced by 
most alcohol-dependent individuals, a pattern that likely plays a vital role in the enduring 
maintenance of excessive drinking (Sanchis-Segura & Spanagel, 2006). 
 Another popular conceptual variant of the ADE is the “every-other-day” (EOD) 
protocol, where intervals of continuous ethanol access and deprivation are alternated 
every 24-hours. Although this model was introduced shortly after characterization of the 
ADE (Wise, 1973), and is similar to the RADE in principle, the EOD involves more rapid 
cycling between drinking and non-drinking days. The EOD procedure has been shown 
to accelerate the rate at which both rats (Wise, 1973; Carnicella, Amamoto, & Ron, 
2009; Hargreaves, Monds, Gunasekaran, Dawson, & McGregor, 2009; Loi et al., 2010; 
Simms et al., 2008) and mice (Hwa et al., 2011; Melendez, 2011; Rosenwasser, Fixaris, 
Crabbe, Brooks, & Ascheid, 2013) exhibit excessive levels of ethanol consumption. This 
work has provided support that exposure to repeated periods of ethanol deprivation is 
likely a crucial factor underlying elevated ethanol intake, as some animals voluntarily 
consume sufficient ethanol to achieve mildly intoxicating BECs and display overt 
behavioral signs of dependence (Hölter, Linthorst, Reul, & Spanagel, 2000; Hwa et al., 
2011; Simms et al., 2008). Nevertheless, inconsistent emergence of the ADE, RADE, or 
EOD effects in studies involving mice, as opposed to rats, has cast doubt on the validity 
of this paradigm (Vengeliene et al., 2014), as, unlike in rats, both single or multiple 
deprivation periods have not consistently resulted in subsequent amplified ethanol 
intake in mice  (Khisti et al., 2006; Melendez et al., 2006).  
 In contrast to high-throughput ethanol-related phenotypes, such as two-bottle 
free-choice drinking, examination of any ADE variant requires substantial time and 
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resources to execute. Therefore, unsurprisingly, there have been a lack of genetic 
diversity approaches implemented towards elucidation of the genetic basis of ADE 
variants. Most mouse studies on intermittent access have exclusively involved B6J mice 
(Hwa et al., 2011; Melendez, 2011; Melendez et al., 2006; Sparta et al., 2009), though a 
few studies have examined more diverse genotypes, including genetically heterogenous 
populations and lines selected for various ethanol-related phenotypes (Ford et al., 2011; 
Rosenwasser et al., 2013). For example, Rosenwasser et al. (2013) characterized the 
effects of intermittent ethanol access in mouse genotypes previously categorized by 
divergent ethanol-related phenotypes for two-bottle free-choice ethanol drinking, binge-
like ethanol drinking, and handling-induced convulsion severity. Interestingly, all tested 
genotypes exhibited escalated ethanol intake in response to intermittent ethanol access, 
with little relevant difference between genotypes. These data suggest there are no 
genetic correlations between the effects of intermittent access and either two-bottle 
free-choice drinking, scheduled access binge-like drinking, or severity of handling-
induced convulsions. 
 However, of particular interest to this dissertation, B6 substrains have been found 
to display differences in expression of the ADE (Khisti et al., 2006). Although baseline 
ethanol intake for B6NCrl mice were considerably lower than B6J mice, they 
consistently demonstrated a robust ADE. Surprisingly, ethanol deprivation in B6J mice 
did not produce significant increases in ethanol consumption or preference. Despite the 
possibility of a “ceiling effect” with regards to B6J mice in this study, these results 
suggest that B6NCrl mice may serve as a valuable tool for future analyses on the 
molecular mechanisms of craving and drinking behavior. Nonetheless, future work 
23 
 
involving greater utilization of genetic diversity approaches, such as selectively-bred 
lines, RI strains, CC and DO mice, and perhaps different inbred substrains (e.g., B6NJ), 
would likely reveal a more complete picture of the specific genes driving expression of 
the ADE. 
1.2.3. Drinking-in-the-Dark 
 Although ADE protocols (and slight variants thereof) have been successful at 
initiating brief escalations in voluntary ethanol intake, more recent development have 
explicitly focused on producing pharmacologically relevant BECs over a defined period 
of time. Specifically, the goal of the “Drinking-in-the-Dark” (DID) paradigm is to provide a 
valid animal model of non-dependent binge-like drinking that reliably results in BECs 
above 80 mg/dL, thereby satisfying the clinical criteria for a binge put forth by the 
National Institute of Alcoholism and Alcohol Abuse (NIAAA) (Thiele & Navarro, 2014). 
 Since rodents are nocturnal, their levels of food and fluid consumption, as well as 
general activity, are highest during their dark phase (Dole & Gentry, 1984); thus, 
providing scheduled access to ethanol during the dark phase of their circadian cycle has 
been shown to facilitate greater ethanol consumption (Ryabinin, Galvan-Rosas, 
Bachtell, & Risinger, 2003). In this model, mice are maintained under a standard light-
dark (LD) cycle and given a 2-hour access period to a single bottle containing 20% 
ethanol, beginning three hours into their dark phase (Rhodes, Best, Belknap, Finn, & 
Crabbe, 2005; Rhodes et al., 2007). This procedure is followed for three consecutive 
days, while on the fourth day, the access period is extended an additional two hours 
(food is available ad libitum). This model was specifically developed with B6J mice, 
who, on the final day of the 4-day DID procedure, showed significant ethanol 
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consumption that produced BECs upwards of 100 mg/dL (Rhodes et al., 2005). 
Additionally, following a 4-day DID procedure, B6J mice exhibited observable signs of 
intoxication, such as impaired motor coordination (Rhodes et al., 2007). 
 While systematically developing the DID paradigm, Rhodes et al. (2005) noticed 
a pronounced influence of the length of time into the dark phase ethanol access was 
allowed and subsequent ethanol intake. Mice drank significantly more ethanol and 
achieved higher BECs when ethanol was offered three hours into the dark phase, 
relative to either one or two hours into the dark phase. These results infer the success 
of the DID procedure is strongly dependent on the time within the animal’s circadian 
rhythm at which ethanol access occurs. Additionally, postponing ethanol access until 
four hours into the dark phase did not significantly change ethanol intake levels or 
BECs, compared to offering ethanol access three hours into the dark phase. 
Interestingly, Rhodes et al. (2005) also tested whether 10%, 20%, or 30% ethanol 
produced optimal intake levels in the DID, but found no significant differences and 
chose to use 20% for subsequent experiments. Further experimentation with the DID 
paradigm incorporated a two-bottle choice, allowing water access simultaneously with 
ethanol access, and noted moderate reductions in ethanol intake and resulting BECs, 
as would be expected (Rhodes et al., 2007). 
 Of particular importance is that the high levels of intake produced by the DID 
procedure appear to be unrelated to motivation for obtaining calories contained in 
ethanol (Lyons, Lowery, Sparta, & Thiele, 2008). Moreover, while extending the initial 3 
days of 2-hour access periods to 14 days produced quicker rates of consumption and 
tolerance to the ataxic effects of ethanol (Linsenbardt, Moore, Griffin, Gigante, & 
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Boehm, 2011), repeated DID episodes (up to 10, 4-day DID cycles) did not promote 
significant differences in the level of binge-like ethanol drinking (Cox et al., 2013). 
Overall, the DID procedure possesses significant face validity in terms of modeling 
human binge drinking since mice exhibit binge-like drinking under conditions of short-
term oral ethanol consumption that results in BECs exceeding the threshold of 
intoxication. Its high-throughput approach has proven useful for screening 
pharmacological targets that are effective in the mitigation of non-dependent binge-like 
drinking (Sprow & Thiele, 2012; Thiele & Navarro, 2014). 
 Although the DID procedure was developed using B6J mice, researchers have 
since evaluated potential strain differences (Crabbe et al., 2012; Rhodes et al., 2007). 
For example, Rhodes et al. (2007) administered the DID procedure to a panel of 12 
standard inbred strains and found that B6J mice exhibited the highest levels of ethanol 
intake and consequent BECs, while D2J mice demonstrated the lowest, a pattern which 
correlates to a significant degree with two-bottle free-choice drinking from inbred strain 
panel studies (Crabbe et al., 2012). In addition to the observed strain effects for both 
ethanol intake and resultant BECs, high-drinking and low-drinking strains exhibited 
differential patterns of consumption across days. The four high-drinking strains (B6J, 
BALB/cJ, BALB/cByJ and FVB/NJ), as well as one intermediate-drinking strain 
(C3H/HeJ), consumed a steady amount of ethanol during the two hours of each day’s 
access period, whereas two low-drinking strains (129S1/SvlmJ and D2J) and three 
intermediate-drinking strains (CBA/J, BTBR and A/J) drank significantly less ethanol on 
Days 2-4 than Day 1. When specifically examining Day 4 data, strain differences 
explained 53% and 51% of the variance in ethanol intake and resultant BECs, 
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respectively. B6J mice had a significant influence on these effect sizes, since removing 
B6J animals from the analysis lowered the variance explained by strain to 36% for 
ethanol intake and 21% for BECs. These data imply that pharmacologically significant 
drinking, in B6J mice, is under substantial genetic control and that B6J mice are 
genetically predisposed to high ethanol consumption relative to other inbred strains. 
 More recently, mice have been selectively-bred for high BECs produced by a 2-
day variation of the DID procedure (i.e., access to 20% ethanol for two hours on Day 1 
and four hours on Day 2). Two replicate lines, termed “high-drinking-in-the-dark” (HDID) 
were originally selected from a genetically heterogeneous stock (HS/Npt) and, after 11 
generations of selective breeding, approximately half of HDID mice exhibited BECs 
above 100 mg/dL after undergoing the modified 2-day DID procedure (Crabbe et al., 
2009). Although realized heritability of this trait is relatively low (h2 = .09) in both 
replicate HDID lines, subsequent selection has successfully increased BECs across 
generations. After 27 selected generations of HDID-1 mice, and 19 selected 
generations of HDID-2 mice, BECs had roughly increased 4-5-fold since initial selection 
(Crabbe et al., 2014). Notably, the high BECs of HDID mice, from either replicate line, is 
not due to potential differences in ethanol metabolism, as the rate of elimination of an 
acute ethanol injection did not differ between HDID lines and genetically heterogeneous 
(HS/Npt) mice (Crabbe et al., 2009; 2014). 
 Although inbred strain panels and selective breeding approaches have already 
been implemented for discovering genetic contributions of binge-like drinking, further 
work involving RI strains, CC and DO mice, and inbred substrains would greatly benefit 
these ongoing efforts. In turn, Experiment 2 of this dissertation compared B6J and B6NJ 
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substrains on binge-like drinking via a 4-day DID procedure in an effort to not only 
observe potential substrain differences, but to examine their possible correlation with 
voluntary ethanol consumption and preference under two-bottle free-choice conditions 
(Experiment 1). 
1.2.4. Induction of Ethanol Dependence 
 Since rodents generally do not willingly consume a sufficient volume of ethanol to 
produce sustained, pharmacologically-relevant BECs, forced ethanol delivery methods 
have been developed to induce experimental ethanol dependence in rodents (H. C. 
Becker & Ron, 2014; Holleran & Winder, 2017; Lovinger & Crabbe, 2005). The most 
commonly utilized forced ethanol protocols are intragastric ethanol infusion, 
maintenance on an ethanol liquid diet, and forced inhalation of volatilized ethanol (H. C. 
Becker, 2000; H. C. Becker & Ron, 2014). 
 Intragastric infusion involves direct delivery of ethanol through a tube surgically 
implanted into the animal’s stomach. Although this method provides experimenter 
control over various ethanol exposure parameters (i.e., initiation, duration, and 
termination), it has several disadvantages, such as degree of invasiveness, requirement 
of surgery, restricted number of animals that can be tested simultaneously, and the 
increased likelihood of inflicting unnecessary stress on the animal (Tabakoff & Hoffman, 
2000). Another method, maintenance on an ethanol liquid diet, was developed in an 
attempt to model clinically-relevant ethanol intake while maintaining dietary control 
(Lieber & DeCarli, 1982). In this procedure, animals are offered a single bottle 
containing a liquid diet that is formulated to meet or exceed minimum nutritional needs. 
After a period of acclimation to the liquid diet, ethanol is introduced within the liquid diet, 
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and animals are essentially forced to consume ethanol in order to meet their caloric 
needs (Lieber & DeCarli, 1989). In contrast to other forced administration methods, 
liquid diet relies heavily on the animal’s consummatory behavior and is inherently more 
time-consuming to implement. Overall, both intragastric infusion and ethanol liquid diets 
have been most commonly utilized to reproduce and study several pathophysiological 
complications typically present in alcohol-dependent individuals, such as ethanol-
induced hyperlipemia and cirrhosis (Lieber, DeCarli, & Sorrell, 1989). 
 Forced inhalation of volatilized ethanol vapor has become the preferred method 
of ethanol dependence induction, as it encapsulates most of the advantages and 
mitigates many disadvantages of aforementioned methods. In particular, ethanol vapor 
exposure allows 1) physiological dependence to be established in a comparatively 
minimal period of time, 2) animals to remain in reasonably stable health due to 
minimization of body weight and body temperature loss during intoxication, even when 
undergoing multiple cycles of intoxication/abstinence, 3) control over the initiation, 
duration, and termination of ethanol exposure, and 4) modulation of ethanol dosage 
such that subsequent BECs are consistently maintained between 150-200 mg/dL 
(Becker, 2013). However, ethanol vapor exposure is not a perfect model, as it 
completely bypasses the active consummatory behavioral component that is 
fundamental to addiction. Despite this deficiency in face validity, it has proven to be a 
useful tool for the investigation of various withdrawal-related phenomena, such as 
central nervous system (CNS) hyperexcitability, dependence-induced escalation of 
voluntary ethanol drinking, and anxiety- and/or depressive-like behavior during long-
term abstinence (H. C. Becker & Ron, 2014; Heilig et al., 2010). In numerous instances, 
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chronic ethanol vapor exposure, but not intragastric infusion, has been shown to result 
in increased voluntary drinking during withdrawal (W. C. Griffin, Lopez, Yanke, 
Middaugh, & Becker, 2009b).  
 Chronic ethanol vapor exposure can be delivered in either a continuous 
(Goldstein & Pal, 1971; Metten & Crabbe, 2005) or intermittent (Lopez & Becker, 2005; 
Metten, Sorensen, Cameron, Yu, & Crabbe, 2010) manner, which, in the latter case, 
contains multiple abstinence episodes embedded within the overall exposure protocol. 
Previous evidence of chronic-intermittent ethanol (CIE) vapor exposure suggests that 
the severity of withdrawal-related symptoms may develop in a cumulative manner. This 
“kindling hypothesis” postulates that progressive intensification of the symptomatology 
is a direct consequence of repeated episodes of ethanol intoxication and abstinence 
(Ballenger & Post, 1978; H. C. Becker & Hale, 1993; H. C. Becker, Diaz-Granados, & 
Weathersby, 1997). 
1.2.5. Escalated Voluntary Ethanol Intake Following Dependence Induction 
 Unfortunately, relapse occurs after either short or long periods of abstinence in 
the majority of post-dependent individuals (Barrick & Connors, 2002), an observation 
which supports the AUD criterion describing uncontrollable compulsions to seek and 
consume ethanol (Mason, 2017). Several procedural variations have been deployed in 
attempting to model this behavior. The most common and reliable method involves 
initial limited-access or continuous free-choice drinking, followed by induction of 
dependence via chronic ethanol vapor exposure and subsequent access to ethanol (in 
the respective manner originally used) during ensuing abstinence (Becker, 2013). 
Typically, prominent increases in ethanol intake are observed (H. C. Becker & Lopez, 
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2004; Finn et al., 2007; Lopez & Becker, 2005; McCool & Chappell, 2015; A. J. Roberts, 
Heyser, Cole, Griffin, & Koob, 2000) and are thought to reflect an attempt to reduce 
associated withdrawal symptoms (Heilig et al., 2010; Holleran & Winder, 2017). 
 Interesting, more robust ethanol intake is exhibited during abstinence when 
ethanol vapor is administered on an intermittent, rather than continuous, manner (W. C. 
Griffin, Lopez, & Becker, 2009a; O' Dell, Roberts, Smith, & Koob, 2004). These results 
demonstrate that escalated ethanol consumption is not simply a product of chronic 
ethanol exposure, but rather, likely due to the repeated enforcement of abstinence 
periods. In turn, increasing the total number of CIE cycles results in corresponding 
escalations in ethanol intake (W. C. Griffin, Lopez, Yanke, Middaugh, & Becker, 2009b), 
as well as more enduring intake further into abstinence (Lopez & Becker, 2005). 
Moreover, this effect seems to be ethanol-specific, as no alterations in either water or 
sucrose consumption were observed following CIE termination (H. C. Becker & Lopez, 
2004; Lopez & Becker, 2005; Lopez, Griffin, Melendez, & Becker, 2012); thus, 
increased ethanol intake is not indicative of an idiopathic desire for fluid or calories. It is 
often postulated that this model of post-dependent relapse reflects the transition from 
drinking motivated by positive reinforcement to drinking driven by negative 
reinforcement (i.e., alleviation of unpleasant withdrawal-related symptoms). It is this 
transition that is possibly intensified by repeated cycles of abstinence and relapse, 
resulting in uncontrollable consummatory compulsions in order to avoid the negative 
reinforcing properties of ethanol. 
 Unsurprisingly, the vast majority of studies involving dependence-induced 
escalation of voluntary ethanol intake exclusively use B6J mice (H. C. Becker & Lopez, 
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2004; Finn et al., 2007; W. C. Griffin, Lopez, & Becker, 2009a; W. C. Griffin, Lopez, 
Yanke, Middaugh, & Becker, 2009b; Lopez et al., 2012; Lopez & Becker, 2005; Lopez, 
Becker, & Chandler, 2014), as their general avidity to consume greater quantities of 
ethanol, relative to other inbred strains, in various ethanol intake protocols, renders 
them an ideal model. However, this choice sacrifices the ability to detect and 
characterize underlying genetic contributions. More recently, McCool & Chappell (2015) 
compared dependence-induced escalation of voluntary ethanol drinking in B6J and D2J 
mice. Since D2J mice reliably exhibit low levels of voluntary ethanol intake, the 
researchers employed a novel tastant-substitution procedure involving monosodium 
glutamate (MSG) that has previously been shown to amplify ethanol consumption in 
characteristically low-drinking strains (McCool & Chappell, 2012; 2014). Overall, 
although the MSG substitution procedure greatly facilitated ethanol intake in D2J mice 
(as well as B6J, although to a lesser degree), ethanol dependence, via forced inhalation 
of ethanol vapor, increased ethanol intake regardless of strain. 
 These data are informative and represent a step in the right direction regarding 
utilizing diverse genotypes. However, the major disadvantage of investigating 
dependence-induced escalation of voluntary ethanol drinking is its required investment 
of significant time, labor, and resources. The intrinsic nature of this phenotype prohibits 
it from being high-throughput, which has likely discouraged genetic discovery 
investigations up to this point. Nevertheless, researchers often acknowledge the need 
for the characterization of complex phenotypes involving powerful genetic tools (i.e., 
selected lines, inbred strain panels, RI strains, CC and DO mice, and/or inbred 
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substrains). While commitment to such a project would be substantial, it is absolutely 
justified in what could be learned. 
1.2.6. Acute Physiological Effects of Ethanol Withdrawal 
 The emergence of overt withdrawal symptoms when ethanol is discontinued is 
generally thought to be indicative of a state of ethanol dependence (Kalant et al., 1971). 
In mice, the most frequently studied index of acute withdrawal severity is the handling-
induced convulsion (HIC) test, which serves as a marker for CNS hyperexcitability (H. 
C. Becker et al., 1997; H. C. Becker & Hale, 1993; Goldstein, 1972; Goldstein & Pal, 
1971). Interestingly, in contrast to mice, rats do not exhibit HICs, thus withdrawal 
severity is generally indexed by a collection of other behavioral and physiological 
disturbances (Majchrowicz, 1975; Heilig et al., 2010). Nonetheless, the HIC measure, in 
mice, effectively models certain aspects of the acute alcohol withdrawal syndrome often 
observed in alcohol-dependent individuals. In humans, symptom onset is typically within 
eight hours of initial abstinence, and can include irritability, nausea, vomiting, insomnia, 
tremor, hyperalgesia, hyperthermia, tachycardia, anxiety, hallucinations, delusions, and 
tonic-clonic seizures (APA, 2013; Attilia et al., 2018). Mouse responses typically range 
from mild myoclonic twitches to tonic-clonic convulsions, though severely dependent 
mice may demonstrate fatal tonic hindlimb extensor seizures (Metten & Crabbe, 2005). 
HICs in mice usually peak around 7-10 hours following termination of ethanol exposure, 
returning to baseline levels after 24 hours, and its severity is a function of both ethanol 
dose and duration of exposure (H. C. Becker et al., 1997; H. C. Becker & Hale, 1993; 
Goldstein, 1972; Metten et al., 2010; Metten & Crabbe, 2005). 
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Various approaches have been employed to examine the underlying genetic 
contributions to HICs during acute ethanol withdrawal. Beginning in 1983, the Crabbe 
laboratory has used bidirectional selective breeding of genetically heterogeneous mice 
(HS/Ibg) from an 8-way cross of inbred strains to develop multiple stable lines of 
Withdrawal Seizure-Prone (WSP) and Withdrawal Seizure-Resistant (WSR) mice 
displaying high and low HIC scores, respectively, following 72-hour ethanol vapor 
exposure (Crabbe, Kosobud, & Young, 1983; Crabbe, Kosobud, Young, Tam, & 
McSwigan, 1985). As is ideal, the experiment was repeated in order to generate a 
second, genetically independent pair of bidirectionally selected lines (WSP-1, WSP-2; 
WSR-1, WSR-2). After 11 generations of selection, heritability of the trait was moderate 
(h2 = .26), and both WSP lines exhibited at least tenfold more severe HICs than their 
respective WSR lines (Crabbe et al., 2013). 
These selected lines have been tested for differences on various other ethanol-
related phenotypes, with mixed results. For example, although WSP and WSR mice 
show differences in DID drinking (Crabbe et al., 2013), they do not significantly differ in 
two-bottle free-choice ethanol drinking, operant ethanol self-administration, or 
expression of the ADE (Crabbe et al., 2013; Ford et al., 2011; Rosenwasser et al., 
2013). Also, a recent experiment by our laboratory (Hartmann, Holbrook, Haney, 
Crabbe, & Rosenwasser, 2019) found no significant differences in abstinence-induced 
anxiety- and/or depressive-like behavior between WSP-2 and WSR-2 mice, providing 
evidence that acute and long-term consequences of ethanol withdrawal appear to be 
dependent on largely non-overlapping gene networks. 
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Several studies have documented inbred strain differences in HIC severity. For 
instance, Metten & Crabbe (2005) found significant strain differences in a panel of 15 
inbred strains. Intriguingly, this study used a standard 72-hour continuous ethanol vapor 
exposure period, but attempted to produce nearly identical resultant BECs by exposing 
different strains to different ethanol vapor concentrations. Ironically, strain differences in 
HIC severity was independent of dose administered. Similarly, Metten et al. (2010) 
characterized the same 15 inbred strains for HIC severity following CIE (16 hours/day 
ethanol vapor with 8 hours exposure to air), as opposed to continuous vapor exposure. 
Collectively, these two studies revealed two important insights, 1) D2J mice consistently 
displayed among the highest HIC scores, while B6J mice regularly presented among 
the lowest, and 2) there appears to be an inverse genetic relationship between two-
bottle free-choice ethanol drinking and HIC severity, a finding supported by previous 
work (Hitzemann et al., 2009; Metten et al., 1998). 
Along these lines, prior work has utilized RI strains of mice derived from B6J and 
D2J crosses (BXD) to map QTLs for HIC severity following ethanol vapor exposure 
(Crabbe, 1998). The first experimental investigation regarding HIC severity following 
chronic ethanol vapor exposure identified a total of 10 QTLS: 2 QTLs on chromosomes 
1 and 9 and single QTLs on chromosomes 3, 10, 12, 13, 15, and 18 (Crabbe, 1998). 
Analysis from the four most influential QTLs (chromosomes 1 (distal), 9 (distal), 13, and 
15) showed that, together, these loci were responsible for approximately 86% of the 
genetic variance. This work stimulated further efforts which revealed the gene encoding 
multiple PDZ domain protein (mpdz) to be a quantitative trait gene (QTG) associated 
with acute ethanol withdrawal HIC severity (Metten et al., 2014; Shirley, Walter, Reilly, 
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Fehr, & Buck, 2004). Future work will hopefully pinpoint the circuits, and possibly 
networks, this gene is exerting influence on, as well as discover and characterize 
potential gene-gene interaction effects. 
1.2.7. Affective Disturbance during Ethanol Withdrawal 
 Although acute physiological symptoms of ethanol withdrawal can be effectively 
managed with benzodiazepines in both rodents (Heilig et al., 2010) and humans (Mayo-
Smith, 1997), such treatments do not significantly decrease the likelihood of eventual 
relapse (Askgaard et al., 2016; Malcolm et al., 2002). Furthermore, much less is known 
concerning the longer-term affective-behavioral disruptions that may emerge weeks to 
months after initial detoxification, and often persist across even prolonged periods of 
abstinence. In affected individuals, persistent anxiety and depressive symptoms may 
contribute to an increased risk of relapse long after acute detoxification (Heilig et al., 
2010; Malcolm, 2003). Additionally, benzodiazepines do not significantly mitigate 
emerging affective disturbances even when administered several weeks into abstinence 
(Gallant, Bishop, Guerrero-Figueroa, Selby, & Phillips, 1969). 
 Experiments employing chronic ethanol vapor exposure have revealed increases 
in anxiety- and/or depressive-like behavior in rats (Valdez et al., 2002; Walker et al., 
2010; Zhao, Weiss, & Zorrilla, 2007) and mice (Logan, McCulley, Seggio, & 
Rosenwasser, 2012; Sidhu, Kreifeldt, & Contet, 2018) several weeks after the 
termination of ethanol exposure. Although chronic ethanol vapor exposure is thought to 
effectively model alcohol-dependent patients exhibiting the highest BECs, there is some 
evidence that such high levels of intoxication may not be necessary for the expression 
of affective disturbances during long-term abstinence (Holleran & Winder, 2017). For 
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example, previous studies in mice (Gong et al., 2017; Holleran et al., 2016; Pang, 
Renoir, Du, Lawrence, & Hannan, 2013; Roni & Rahman, 2017; Stevenson et al., 2009) 
have observed significant depressive-like behavior weeks after termination of long-term 
continuous access to ethanol under two-bottle free-choice conditions. These findings 
suggest that researchers perhaps overestimate the influence of BECs and physical 
withdrawal symptoms to the development of affective disturbances during long-term 
abstinence. 
 Anxiety- and depressive-like rodent behavior appear to follow different temporal 
trajectories following cessation of chronic ethanol exposure. Across diverse ethanol-
administration protocols and behavioral test procedures, rats (Gong et al., 2017; 
Rylkova, Shah, Small, & Bruijnzeel, 2009; Valdez et al., 2002; Van Skike, Diaz-
Granados, & Matthews, 2015; Zhao et al., 2007) and mice (Finn, Gallaher, & Crabbe, 
2000; Gong et al., 2017; Kash, Baucum, Conrad, Colbran, & Winder, 2009; Kliethermes, 
Cronise, & Crabbe, 2004; Perez & De Biasi, 2015; Pleil et al., 2015; Rose et al., 2016) 
usually display significant anxiety-like behavior during the first 72 hours of abstinence, a 
phase referred to as acute withdrawal; however, several negative findings have also 
been reported, especially in mice (Cox et al., 2013; Daut et al., 2015; Lee, Coehlo, 
McGregor, Waltermire, & Szumlinski, 2015; Metten et al., 2017). 
 Four days to three weeks into abstinence is usually referred to as “early 
abstinence” (Heilig et al., 2010). Interestingly, during this period, exhibition of anxiety-
like behavior becomes less prominent in both rats (Rylkova et al., 2009; Zhao et al., 
2007) and mice (J. A. J. Becker, Kieffer, & Le Merrer, 2017; Fukushiro et al., 2012; 
Holleran et al., 2016; Lee et al., 2015; Pang et al., 2013). Although the presence of 
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anxiety-like behavior, in both mice and rats, wanes during early abstinence, anxiety-like 
behavior appears to reemerge in rats (Gillett, Harshberger, & Valdez, 2013; Valdez et 
al., 2002; Zhao et al., 2007), but not mice (J. A. J. Becker et al., 2017; Lee, Coehlo, 
Solton, & Szumlinski, 2017), during “protracted abstinence” (abstinence extending to 
greater than four weeks). 
 In contrast, studies of rodent depressive-like behavior have revealed a temporal 
pattern distinct from manifestations of anxiety-like behavior. During acute withdrawal, 
inconsistent findings regarding depressive-like behavior have been reported, as results 
appear to be largely dependent on the method of ethanol administration, and to some 
extent, the behavioral assay utilized. In mice, forced methods of ethanol administration 
(Arora & Vohora, 2016; Karadayian, Busso, Feleder, & Cutrera, 2013; Metten et al., 
2017), as opposed to voluntary consumption paradigms (Holleran et al., 2016; Lee et 
al., 2015; 2017; 2016; Stevenson et al., 2009), seem to more reliably produce 
depressive-like behavior. Although there are a more limited number of studies involving 
rats, positive results have typically been reported (Getachew, Hauser, Taylor, & Tizabi, 
2010; Jarman, Haney, & Valdez, 2018). 
 There is abundant evidence for the exhibition of depressive-like behavior in mice 
during early abstinence, which does not seem to be influenced by method of ethanol 
administration or behavioral assay variations (Gong et al., 2017; Holleran et al., 2016; 
Kim et al., 2017; Pang et al., 2013; Roni & Rahman, 2017; Stevenson et al., 2009). In 
rats, only two studies have been conducted, and they reflect mixed findings (Jarman et 
al., 2018; Rasmussen, Mitton, Green, & Puchalski, 2001). Currently, there is a relative 
dearth of studies analyzing depressive-like behavior during protracted abstinence in 
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either rats or mice, denoting a significant gap in the literature. Nonetheless, both rats 
(Rasmussen et al., 2001; Walker et al., 2010) and mice (Lee et al., 2017; Logan et al., 
2012) have displayed contradictory results, restricting the ability to draw concrete 
conclusions. 
 Unfortunately, researchers have not utilized genetic diversity approaches in the 
investigation of affective disturbance during ethanol withdrawal, as the overwhelming 
majority of studies involve B6J mice. On occasion, B6J mice have been compared to a 
different inbred strain, such as D2J and C3H mice (Finn et al., 2000; Logan et al., 2012; 
McCool & Chappell, 2015; Sidhu et al., 2018), though these comparisons have yielded 
inconsistent results that are likely influenced by differences in the method of 
dependence induction and behavioral assay utilized. For instance, during acute 
withdrawal, both D2J and B6J mice exhibited significant anxiety-like behavior on the 
elevated-plus maze (EPM) (Finn et al., 2000), but only D2J, and not B6J, displayed 
significant anxiety-like behavior on the LDT (McCool & Chappell, 2015). Furthermore, 
during early abstinence, both D2J and B6J mice exhibited significant anxiety-like 
behavior on the marble burying test (MBT) (Sidhu et al., 2018). Interestingly, the most 
convincing evidence for strain differences in withdrawal-associated depressive-like 
behavior involved extended analysis into protracted abstinence. Following termination of 
a 4-cycle CIE exposure, B6J mice demonstrated dramatic hypolocomotion for up to 7 
days whereas C3H mice sustained hypolocomotion up to 30 days (Logan et al., 2012). 
 Although these aforementioned data are important, there is no previous data 
involving selected lines, inbred strain panels, RI strains, CC and DO mice, or inbred 
substrains in regards to affective disturbances during ethanol withdrawal. As previously 
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discussed, a major disadvantage of investigating certain phenotypes, such as affective 
behavior during long-term ethanol abstinence, is its degree of labor intensiveness. This 
inherent aspect of this line of research is likely the reason such genetic discovery 
investigations are currently absent. Nevertheless, future work involving diverse genetic 
approaches and better standardization of methods is needed in order to enhance our 
understanding of the various factors inherent to the emergence of affective disturbances 
during long-term ethanol abstinence. To this end, Experiment 3 of this dissertation 
compared B6J and B6NJ substrains on long-term anxiety- and depressive-like behavior 
following termination of chronic ethanol vapor exposure in hopes of initiating future 
genetic discovery investigations utilizing such framework. 
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CHAPTER 2 
EXPERIMENT 1: SUBSTRAIN DIFFERENCES IN FREE-CHOICE ETHANOL 
DRINKING AND WHEEL-RUNNING BETWEEN C57BL/6J AND C57BL/6NJ MICE: 
ROLE OF CYFIP2 
2.1. Rationale 
 In the present experiment, voluntary ethanol consumption and preference, as 
well as wheel-running, were examined in male and female B6J, B6NJ, CRISPR-B6JNJ/NJ 
(B6JNJ/NJ) and CRISPR-B6NJJ/J (B6NJJ/J) mice. Previous work has identified a SNP in 
the Cytoplasmic FMR1-interacting protein 2 (Cyfip2) gene that underlies the differential 
locomotor response to cocaine exhibited by B6J and B6N mice (Kumar et al., 2013). In 
addition, phylogenetic analysis of Cyfip2 variation within B6 substrains found that this 
SNP became fixed in the B6N strain sometime between 1961-1974; consequently, all 
B6N derivatives possess this mutation as well. Thus, we hypothesized that this cocaine-
relevant SNP in Cyfip2 also contributes to other addiction-related phenotypic differences 
between B6 substrains. Since B6J mice reliably exhibit higher ethanol consumption and 
preference than B6N mice from various breeding locations (Blum et al., 1982; Mulligan 
et al., 2008; Ramachandra et al., 2007), we expected B6J mice to exhibit significantly 
greater ethanol consumption and preference than B6NJ mice. In turn, we hypothesized 
that insertion of the mutant B6NJ Cyfip2 SNP into the B6J background (B6JNJ/NJ) would 
significantly reduce ethanol consumption and preference, while “correcting” the B6NJ 
Cyfip2 mutation by inserting the B6J Cyfip2 SNP into the B6NJ background (B6NJJ/J) 
would significantly increase ethanol consumption and preference. 
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 Wheel-running was also examined in these inbred substrains and associated 
CRISPR-engineered lines since previous work suggests wheel-running is a rewarding 
and reinforcing behavior that depends on overlapping neural circuitry that mediates drug 
reward and addiction (Brené et al., 2007; de Visser, van den Bos, Stoker, Kas, & Spruijt, 
2007). Wild mice will engage in wheel-running, even within a natural environment and 
when no extrinsic reward is provided (Meijer & Robbers, 2014), whereas laboratory 
rodents will actively press a lever to gain access to a running-wheel and reliably develop 
a conditioned place preference for an environment previously paired with a running-
wheel (Belke, 1997; Lett, Grant, Byrne, & Koh, 2000). Though no previous work has 
examined potential differences in wheel-running specifically between B6J and B6NJ 
mice, prior work has demonstrated that B6N mice display higher daily wheel-turns than 
B6J mice under constant darkness (Kumar et al., 2013). Additionally, while traditional 
QTL mapping failed to identify any significant QTLs, reanalysis of these data through 
utilization of mean-variance QTL mapping identified one QTL on chromosome 6 (Corty, 
Kumar, Tarantino, Takahashi, & Valdar, 2018). Therefore, we sought to characterize 
this phenotype and assess, if differences were present, the relative contribution of the 
Cyfip2 SNP. 
2.2. Materials and Methods 
2.2.1. Animals 
 Male and female B6J (M, n = 14; F, n = 16), B6NJ (M, n = 14; F, n = 16), B6JNJ/NJ 
(M, n = 13; F, n = 12), and B6NJJ/J (M, n = 11; F, n = 13) mice were shipped to the 
University of Maine from The Jackson Laboratory (Bar Harbor, ME). Specifically, Cyfip2 
Knock-in mice (B6JNJ/NJ, B6NJJ/J) were generated and supplied by Dr. Vivek Kumar, 
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who utilized CRISPR-Cas9 gene editing to introduce the heterotypical SNP of the 
Cyfip2 gene into an otherwise normal B6J or B6NJ genetic background. Mice arrived in 
the laboratory at approximately 6 weeks of age and were immediately individually 
housed in running-wheel cages (32 x 20 x 14 cm) under a LD 12:12 lighting regimen 
(lights off at 1400) for the duration of the experiment. Running-wheel cages were placed 
within light-shielded and sound-attenuating metal cabinets equipped with standard 
fluorescent bulbs on each shelf. Food (Prolab RMH 3000; LabDiet, St. Louis, MO) and 
tap water were available ad libitum throughout the experiment. During the two-bottle 
free-choice ethanol drinking protocol, ethanol solutions of various concentrations were 
available via a second drinking bottle, as described below. All experimental procedures 
were approved by the University of Maine Institutional Animal Care and Use Committee 
(IACUC). 
2.2.2. Procedures 
 24 hours following arrival, animals underwent a 15-day period in the running-
wheel cages with ad libitum access to food and water (but not ethanol). Subsequently, 
all animals underwent a two-bottle free-choice ethanol drinking protocol; running wheels 
remained available throughout ethanol testing. There were 10-16 animals for each 
sex/substrain combination; exact n’s for each group are available for ethanol analyses 
and wheel-turn per day analyses in Fig. 2.2 and Fig. 2.6, respectively. Due to running-
wheel equipment error, data were unavailable for a small subset of animals (B6JNJ/NJ, n 
= 2; B6NJJ/J, n = 4) that were thus excluded from analyses of daily activity. 
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2.2.2.1. Wheel-Running 
 Animals were given continuous access to a running-wheel (wheel diameter: 23 
cm; Mini-Mitter Co., Bend, OR) for the duration of the experiment. All wheel-turns were 
recorded using the ClockLab interface system (Actimetrics Co., Wilmette, IL). Daily 
wheel-turns during the 15-day period prior to ethanol access were used for data 
analysis. 
2.2.2.2. Two-Bottle Free-Choice Ethanol Consumption 
 Animals were given continuous free-choice access to bottles containing either an 
ethanol solution or plain water for a total of 35 days. Ethanol concentration was initially 
set at 3% (v/v) and increased in 3% increments, every 5 days, through a final 
concentration of 21%. The physical location (right or left) of the water and ethanol 
solutions was switched every 5 days, in a counterbalanced manner, to reduce the 
effects of potential side preference. Pre- and post-measurements of bottle weight, along 
with animals’ respective body weights following each 5-day period of ethanol access 
(data not shown), were used to obtain accurate calculations of body weight-adjusted 
ethanol intake (g/kg) over the course of the experiment. Ethanol preference was 
determined by dividing the volume of ethanol solution consumed by total fluid intake. 
2.2.2.3. Statistics 
 Data are presented as means +/- SEM. Ethanol intake and preference were 
analyzed using 3-factor (genotype, sex, concentration) mixed-design analysis of 
variance (ANOVA) followed where appropriate by separate 2-factor ANOVAs. Similarly, 
wheel-turns per day was analyzed using 3-factor (genotype, sex, day) mixed-design 
ANOVA, followed where appropriate by separate 2-factor ANOVAs. Data analysis was 
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performed using SPSS 23.0 (IBM Inc., Armonk, NY) and figures were generated using 
SigmaPlot 10.0 (Systat Software Inc., San Jose, CA). Only statistically significant (p < 
.05) main effects and interactions are described in the text, and while exact p-values are 
not given for pairwise comparisons, all mentioned pairwise tests were significant at p < 
.05. 
2.3. Results 
2.3.1. Two-Bottle Free-Choice Ethanol Consumption 
2.3.1.1. Ethanol Intake 
 ANOVA revealed significant main effects of genotype [F(3, 101) = 11.58, p < 
.001, partial 𝜂" = .256], sex [F(1, 101) = 41.44, p < .001, partial 𝜂" = .291], and 
concentration [F(6, 606) = 76.268, p < .001, partial 𝜂" = .430], as well as significant 
genotype x sex [F(3, 101) = 3.37, p = .021, partial 𝜂" = .091], genotype x concentration 
[F(6, 606) = 2.40, p = .001, partial 𝜂" = .066], and sex x concentration [F(6, 606) = 7.71, 
p < .001, partial 𝜂" = .071] interactions (Fig. 2.1).  
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Figure 2.1. Ethanol intake across concentrations. Mean (±SEM) ethanol intake 
(g/kg/day) during two-bottle free-choice in C57BL/6J (J), C57BL/6NJ (NJ), CRISPR-
B6JNJ/NJ (JNJ/NJ), and CRISPR-B6NJJ/J (NJJ/J) mice. Symbols denote the following 
significant differences (p < .05): a = J > NJ, b = J > JNJ/NJ, c = J > NJJ/J, d = JNJ/NJ > NJ. 
 
 Ethanol intake generally increased as a function of concentration. Females 
displayed significantly greater intake than males, both overall and at each concentration 
except 3% and 9%. B6J mice displayed significantly greater overall intake than any 
other genotype, but pairwise comparisons among genotypes varied as a function of 
concentration. Specifically, B6J mice displayed significantly greater intake than B6NJ 
mice at all concentrations of 9% and higher; B6J displayed significantly greater intake 
than B6JNJ/NJ mice at concentrations of 12%, 18%, and 21%; and B6J displayed 
significantly greater intake than B6NJJ/J mice at concentrations of 12% and greater. 
While B6JNJ/NJ exhibited greater intake than B6NJ overall, this effect was significant only 
at 15% concentration (Fig 2.1). Finally, while B6NJJ/J showed significantly greater 
overall intake than B6NJ, this effect was not significant at any specific concentration. 
Separate analyses for females and males (Fig. 2.2) showed that female B6J mice 
displayed significantly greater intake than females of any other genotype, whereas 
among males, B6J mice displayed significantly greater intake than B6NJ and B6JNJ/NJ, 
but not B6NJJ/J mice. Finally, male B6NJ mice exhibited significantly lower intake than 
any other genotype. 
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Figure 2.2. Total ethanol intake across sex. Mean (±SEM) total ethanol intake (g/kg) 
during two-bottle free-choice in female (top) and male (bottom) C57BL/6J (J), 
C57BL/6NJ (NJ), CRISPR-B6JNJ/NJ (JNJ/NJ), and CRISPR-B6NJJ/J (NJJ/J) mice. Bars with 
no shared letters are significantly different (p < .05) from one another. 
 
2.3.1.1. Ethanol Preference 
 ANOVA revealed significant main effects of genotype [F(3, 101) = 8.41, p < .001, 
partial 𝜂" = .200], sex [F(1, 101) = 8.43, p = .005, partial 𝜂" = .077], and concentration 
[F(6, 606) = 7.59, p < .001, partial 𝜂" = .070], as well as significant genotype x sex [F(3, 
101) = 4.45, p = .005, partial 𝜂" = .119] and sex x concentration [F(6, 606) = 3.39, p = 
.003, partial 𝜂" = .032] interactions (Fig. 2.3). 
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Figure 2.3. Ethanol preference across concentrations. Mean (±SEM) ethanol preference 
during two-bottle free-choice in C57BL/6J (J), C57BL/6NJ (NJ), CRISPR-B6JNJ/NJ 
(JNJ/NJ), and CRISPR-B6NJJ/J (NJJ/J) mice. 
 
 Ethanol preference was mostly stable, though lower preference was generally 
observed at 15% and higher concentrations. Females displayed significantly higher 
preference than males overall, and at 15% and higher concentrations. B6NJ mice 
exhibited significantly lower preference than all other genotypes. Separate analyses for 
females and males (Fig. 2.4) showed that female B6J mice displayed significantly 
greater preference than both B6NJ and B6NJJ/J, but not B6JNJ/NJ, females, whereas 
male B6NJ mice showed significantly lower preference than all other genotypes. 
 
Figure 2.4. Ethanol preference across sex. Mean (±SEM) ethanol preference during 
two-bottle free-choice, collapsed across concentration, in female (top) and male 
(bottom) C57BL/6J (J), C57BL/6NJ (NJ), CRISPR-B6JNJ/NJ (JNJ/NJ), and CRISPR-
B6NJJ/J (NJJ/J) mice. Bars with no shared letters are significantly different (p < .05) from 
one another. 
 
2.3.2. Wheel-Turns Per Day 
 ANOVA revealed significant main effects of genotype [F(3, 95) = 35.02, p < .001, 
partial 𝜂" = .525], sex [F(1, 95) = 8.32, p = .005, partial 𝜂" = .081], and day [F(14, 1330) 
= 74.16, p = .002, partial 𝜂" = .438], as well as significant genotype x sex [F(3, 95) = 
3.09, p = .031, partial 𝜂" = .089] and genotype x day [F(42, 665) = 2.07, p < .001, partial 
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𝜂" = .062] interactions (Fig. 2.5). Wheel-turns per day generally increased as a function 
of day. Overall, females exhibited significantly higher wheel-turns per day than males, 
B6NJ mice displayed significantly higher wheel-turns per day than all other genotypes, 
and B6NJJ/J mice showed significantly higher wheel-turns per day than both B6J and 
B6JNJ/NJ mice. Specific pairwise comparisons among genotypes varied as a function of 
day (Fig. 2.5). Specifically, B6NJ mice displayed significantly higher wheel-turns per day 
than both B6J and B6JNJ/NJ mice across all days, whereas B6NJ showed significantly 
higher wheel-turns than B6NJJ/J mice only on Days 1, 4, 6-9, and 14; B6NJJ/J mice 
displayed significantly higher wheel-turns per day than B6JNJ/NJ mice, across all days, 
and B6J mice, on each day except Days 1 and 14.  
 
Figure 2.5. Daily wheel-turns across 15-day period. Mean (±SEM) wheel-turns per day 
in C57BL/6J (J), C57BL/6NJ (NJ), CRISPR-B6JNJ/NJ (JNJ/NJ), and CRISPR-B6NJJ/J 
(NJJ/J) mice. Symbols denote the following significant differences (p < .05): a = NJ > J, b 
= NJ > NJJ/J, c = NJ > JNJ/NJ, d = NJJ/J > J, e = NJJ/J > JNJ/NJ. 
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 Separate analyses for females and males (Fig. 2.6) showed that female B6NJ 
and B6NJJ/J mice displayed higher wheel-turns per day than both female B6J and 
B6JNJ/NJ mice. In contrast, male B6NJ mice displayed significantly higher wheel-turns 
per day than all other genotypes, while male B6NJJ/J mice showed significantly higher 
wheel-turns per day than male B6JNJ/NJ mice. 
 
 
Figure 2.6. Daily wheel-turns across sex. Mean (±SEM) wheel-turns per day, collapsed 
across day, in female (top) and male (bottom) C57BL/6J (J), C57BL/6NJ (NJ), CRISPR-
B6JNJ/NJ (JNJ/NJ), and CRISPR-B6NJJ/J (NJJ/J) mice. Bars with no shared letters are 
significantly different (p < .05) from one another. 
 
2.4. Discussion 
 Overall, while this experiment detected significant differences between B6J and 
B6NJ mice in both two-bottle free-choice ethanol drinking and wheel-running, allelic 
variation in Cyfip2 appeared to more substantially modulate substrain differences in 
ethanol intake than in wheel-running. Moreover, observed genotypic effects often 
interacted with other factors, such as sex, ethanol concentration, and/or day of running-
wheel access. 
 Consistent with prior studies (Mulligan et al., 2008; Ramachandra et al., 2007) 
using a different B6N lineage (B6NCrl), B6J mice of both sexes showed greater overall 
ethanol intake and higher levels of ethanol preference compared to B6NJ mice. As 
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expected from the literature, females generally consumed more ethanol than males in 
both B6J and B6NJ, but the substrain difference in ethanol consumption was 
substantially larger in males than in females. 
 While insertion of the mutant B6NJ Cyfip2 SNP into the B6J background 
(B6JNJ/NJ) significantly reduced ethanol intake in both sexes, repairing the B6NJ Cyfip2 
mutation by insertion of the “wild-type” (WT) B6J Cyfip2 SNP into the B6NJ background 
(B6NJJ/J) significantly increased ethanol intake only in males (Fig. 2.2). Further, while 
male B6JNJ/NJ mice showed significantly higher ethanol intake than male B6NJ mice, 
female B6JNJ/NJ mice exhibited similar levels of ethanol intake as did female B6NJ mice. 
Together, these observations suggest that sex-dependent genetic background effects 
may interact with the Cyfip2 SNP to produce observed differences in ethanol intake 
between B6J and B6NJ mice. 
Although there was no a priori hypothesis predicting an asymmetric effect of the 
Cyfip2 mutation, the current data appears to reflect a greater propensity of the mutant 
(B6NJ) Cyfip2 SNP to reduce ethanol intake in an otherwise high-drinking B6J 
background, than of the WT (B6J) Cyfip2 SNP to increase ethanol intake in a 
comparatively low-drinking B6NJ background. It is possible that the WT Cyfip2 gene 
requires sex-specific gene-gene interactions in order to generate the high ethanol intake 
normally seen in B6J mice, while the mutant Cyfip2 SNP is sufficient to yield low ethanol 
intake in either sex. While extensive sex-specific mapping studies would be required to 
identify any genetic modifiers of the Cyfip2 effect, the present results indicate that   
Cyfip2 is a major genetic contributor to the observed substrain differences in ethanol 
intake between B6J and B6NJ mice. 
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 Genotypic differences in ethanol intake also varied as a function of ethanol 
concentration. Thus, B6J mice displayed significantly greater intake than B6NJ mice 
only at concentrations of 9% and higher (Fig. 2.1). This finding differs somewhat from 
previous work comparing B6J to a different B6N lineage (B6NCrl). In that study, which 
utilized the identical series of ethanol concentrations as employed here, B6J mice 
showed higher voluntary ethanol intake at all concentrations, including at 3% and 6% 
(Mulligan et al., 2008). Interestingly, Cyfip2-mediated alterations in ethanol intake were 
highly variable throughout this concentration range. For example, B6J mice 
demonstrated significantly higher ethanol intake than B6JNJ/NJ mice at concentrations of 
12%, 18%, and 21%, but not at 9% or 15%. In addition, though B6NJJ/J showed 
significantly greater overall intake than B6NJ, there were no significant differences at 
any single concentration. It should be noted that our current experimental design, like 
that of Mulligan et al. (2008), used a gradually increasing ethanol concentration series, 
thus confounding time with increasing concentration. That is, we may very well have 
found a different outcome at any specific concentration if we had employed a 
descending concentration series, or even tested independent groups of animals at each 
concentration. On the other hand, mice had five days to consume each respective 
ethanol solution, and previous evidence indicates that approximately four days is the 
optimal duration of two-bottle free-choice access for detecting murine strain differences 
(Tordoff & Bachmanov, 2002). Furthermore, as with any two-bottle free-choice access 
protocol, we are unable to definitively identify the nature of each substrain’s motivation 
to consume a certain ethanol concentration. For example, B6NJ mice might be pursuing 
the taste of ethanol, but B6J mice seek to experience its pharmacological effects. 
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 Similar to ethanol intake, B6J mice of both sexes showed greater overall ethanol 
preference compared to B6NJ mice, consistent with prior work comparing B6J mice to 
B6NCrl mice (Mulligan et al., 2008; Ramachandra et al., 2007). In contrast to our 
ethanol intake data, however, B6JNJ/NJ mice did not display significantly reduced ethanol 
preference relative to B6J in either sex, whereas B6NJJ/J mice exhibited significantly 
increased ethanol preference relative to B6NJ, but only in males (Fig. 2.4). These 
results suggest a stronger effect of the Cyfip2 SNP on ethanol intake than on ethanol 
preference, which was not anticipated. Of course, ethanol preference depends on both 
ethanol intake and water intake, and important differences between ethanol intake and 
preference have historically resulted in a greater emphasis on reporting intake in g/kg 
rather than preference ratios (Crabbe, 2014). For instance, the amount of ethanol 
consumed by an animal typically increases progressively across increasing 
concentrations, until eventually plateauing at high concentrations that may become 
more aversive than pleasurable. In contrast, as increasing concentrations are offered, 
ethanol preference ratios often follow an inverted U-shaped pattern, with the highest 
ethanol preference ratio occurring at a strain-specific intermediate concentration 
(Crabbe, 2014). In addition, some strains may simply show patterns of increasing or 
decreasing preference for ethanol over many days, as ethanol-avoiding animals 
generally exhibit decreased preference across time, whereas ethanol-preferring animals 
typically show increased preference (Blizard et al., 2008). Moreover, our mice had 
access to running-wheels throughout the two-bottle free-choice protocol, which we have 
found typically reduces ethanol preference by increasing water intake, while having little 
effect on ethanol intake. It is likely the conglomeration of these possible factors 
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contributed to the observed differences in Cyfip2-mediated reductions in ethanol intake, 
but not ethanol preference. Nonetheless, Cyfip2 seems to contribute to ethanol 
preference to a lesser degree than ethanol intake. 
 Substrain differences in wheel-running were also observed, but in the direction 
opposite to two-bottle free-choice ethanol drinking differences. Thus, B6NJ mice of both 
sexes showed higher levels of wheel-running than B6J mice, despite the fact that B6J 
are known as a high-running strain. Interestingly, genotypic effects also interacted 
independently with both sex and day. B6JNJ/NJ mice did not display significantly 
increased wheel-running relative to B6J in either sex, yet B6NJJ/J mice exhibited 
significantly decreased wheel-running relative to B6NJ, but only in males (Fig. 2.6). 
These data certainly indicate a more subtle influence of Cyfip2 allelic variation on 
wheel-running compared to two-bottle free-choice ethanol drinking. Furthermore, 
genotypic differences also varied as a function of day. Though B6NJ mice displayed 
significantly higher wheel-turns across all days than both B6J and B6JNJ/NJ mice, B6NJ 
showed significantly higher wheel-turns than B6NJJ/J mice only on Days 1, 4, 6-9, and 
14 (Fig. 2.5). Rodents generally require roughly one week following initial access to an 
in-cage running-wheel to achieve stable activity levels (Cabeza de Vaca et al., 2007; 
Kandasamy, Calsbeek, & Morgan, 2016). Therefore, since the Cyfip2-mediated 
reductions in wheel-running occurred predominately within this time frame, it appears 
the modest influence of Cyfip2 allelic variation is most evident during the “acquisition” 
phase of wheel-running behavior. Since wheel-running is a rewarding and reinforcing 
behavior (Brené et al., 2007; de Visser et al., 2007), it is intriguing that the Cyfip2-
mediated reductions in wheel-running were mostly isolated to the acquisition phase. 
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Nevertheless, Cyfip2 does not appear to be a major contributor to the observed B6 
substrain difference in wheel-running activity. 
 Cyfip2 is primarily expressed in the brain, white blood cells, and kidneys (Su et 
al., 2004). Several whole genome sequencing efforts have revealed Cyfip2 allelic 
variation within B6 substrains (Keane et al., 2011; Simon et al., 2013). Likewise, 
previous QTL experiments have identified the Cyfip2 locus to underlie, at least in part, 
differences in psychostimulant-induced locomotor response between B6J and B6N mice 
(Kumar et al., 2013) and binge-eating between B6J and B6NJ mice (Kirkpatrick et al., 
2017). Interestingly, the Cyfip2 mutation resulted in decreased locomotor response to 
psychostimulants (Kumar et al., 2013) but increased binge-eating (Kirkpatrick et al., 
2017) relative to WT B6J levels, a directional difference that could partly reflect potential 
effects of experimenter-administration versus voluntary consumption. However, our data 
render this possibility unlikely since the Cyfip2 mutation resulted in lowered voluntary 
ethanol intake. 
 Both Kumar et al. (2013) and Kirkpatrick et al. (2017) validated Cyfip2 as a major 
genetic factor underlying their respective phenotype of interest through utilization of 
heterozygous knockout (Cyfip2N/–) mice (since a homozygous Cyfip2 knockout is lethal) 
on a B6N background. However, since the Cyfip2 SNP codes for a S968F missense 
mutation, as opposed to a nonsense mutation, it’s more likely that the translated protein 
interacts with other molecular components that together contribute to behavioral 
alterations. This possibility is reflected in the partial reversal of decreased 
psychostimulant-induced locomotor response, dendritic spine density, glutamatergic 
activity in the nucleus accumbens shell, and increased binge-eating phenotype in 
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Cyfip2N/– mice (Kirkpatrick et al., 2017; Kumar et al., 2013). Similarly, prior work has 
suggested that Cyfip2 helps modulate various processes, such as RNA metabolism 
(Schenck, Bardoni, Moro, Bagni, & Mandel, 2001), actin polymerization (Chen et al., 
2010), axonal guidance (Pittman, Gaynes, & Chien, 2010), and synapse formation 
(Schenck, Bardoni, Langmann, Harden, Mandel, & Giangrande, 2003). Therefore, it is 
possible that Cyfip2-mediated synaptic plasticity alterations, especially within the 
nucleus accumbens, play a significant role in substrain differences in two-bottle free-
choice ethanol drinking. 
 In sum, this experiment indicates that Cyfip2 contributes substantially to 
differences in two-bottle free-choice ethanol drinking between B6J and B6NJ substrains. 
Since observed substrain differences were completely reversed in males, but not 
females, it’s likely that sex-specific contributions from other polymorphisms play a role in 
moderating these effects. In contrast, Cyfip2 appears to have a more modest sex-
specific role in wheel-running differences between B6J and B6NJ substrains, as 
observed substrain differences were only partially reversed in males and completely 
unaffected in females. Therefore, future research should be aimed at identifying gene-
gene interactions and genetic background effects modulating the behavioral effects of 
Cyfip2. 
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CHAPTER 3 
EXPERIMENT 2: BINGE-LIKE DRINKING IN C57BL/6J AND C57BL/6NJ MICE 
3.1. Rationale 
 In the present experiment, male and female B6J and B6NJ mice underwent a 4-
day DID protocol. Because previous studies reveal a positive correlation between binge-
like drinking in the DID test and voluntary ethanol consumption and preference under 
two-bottle free-choice conditions (Crabbe et al., 2012; Rhodes et al., 2007), we 
hypothesized that B6J mice would demonstrate higher levels of binge-like drinking than 
B6NJ mice. Such a result would imply that overlapping sets of genes contribute to both 
degree of voluntary ethanol intake (as measured by two-bottle free-choice) and non-
dependent binge-like drinking (as measured by DID). 
3.2. Materials and Methods 
3.2.1. Animals 
 Male and female B6J (M, n = 10; F, n = 10) and B6NJ (M, n = 9; F, n = 9) mice 
were shipped to the University of Maine from The Jackson Laboratory (Bar Harbor, ME). 
Mice arrived in the laboratory at approximately 6 weeks of age and were immediately 
individually housed in standard mouse cages (30 x 18 x 12 cm) under a reverse LD 
12:12 lighting regimen (lights off at 1200). Cages were placed in a light-shielded and 
sound-attenuating metal cabinet equipped with a standard fluorescent bulb on each 
shelf. Food (Prolab RMH 3000; LabDiet, St. Louis, MO) was available ad libitum 
throughout the experiment, whereas tap water was available ad libitum except during 
single-bottle ethanol access, as described below. All experimental procedures were 
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approved by the University of Maine Institutional Animal Care and Use Committee 
(IACUC). 
3.2.2. Procedures 
 After one week of acclimation, all animals underwent the Drinking-in-the-Dark 
(DID) protocol, a widely accepted mouse model of binge-like ethanol drinking originally 
developed by Rhodes et al. (2005) and described fully below. Immediately following the 
final ethanol access period, blood samples were obtained from all animals for analysis 
of blood ethanol concentration (BEC) (see below). 
 Although animals underwent acclimation to the reverse LD schedule for one 
week before beginning the DID protocol, our first attempt yielded uncharacteristically 
low ethanol intake on Day 4 (data not shown). Since the success of the DID protocol is 
strongly dependent on the time within the animal’s circadian rhythm at which ethanol 
access occurs (Thiele & Navarro, 2014), we suspect that animals were not fully 
entrained to the reverse light-dark schedule by the start of testing. Therefore, animals 
were subsequently given 10 days of additional exposure to the reversed LD cycle, with 
no ethanol access, after which the entire protocol was repeated. We believe that this 
approach is justified by previous work showing stable levels of binge-like ethanol 
drinking even after up to 10 successive 4-day DID episodes (Cox et al., 2013). There 
were 9-10 animals for each sex/substrain combination; exact n’s for each group are 
available in Table 3.1. 
3.2.1. Drinking-in-the-Dark 
 For 3 consecutive days, beginning 3 hours into the dark cycle, water bottles were 
removed from all cages and replaced with bottles containing 20% (v/v) ethanol solution. 
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Mice were given 2 hours of access to ethanol, after which the ethanol bottles were 
removed from cages and water bottles replaced. This same procedure was followed on 
Day 4 except that ethanol access was extended from 2 to 4 hours. Pre- and post-
measurements of bottle weight on each day, along with animals’ initial respective body 
weights (data not shown), were used to obtain accurate calculations of body weight-
adjusted ethanol intake (g/kg). The 4-day DID procedure has been previously shown to 
generate high levels of voluntary ethanol intake and to reliably yield binge-like BECs 
consistent with intoxication (i.e., greater than 80 mg/dl; Rhodes et al., 2005, 2007). 
3.2.2. Measurement of Ethanol Concentrations in Tail Blood  
 BECs were measured immediately following cessation of the ethanol access 
period on Day 4. A small (approximately 10 𝜇L) blood sample was collected from the tip 
of the tail of each mouse and centrifuged for 2 minutes to separate plasma from serum. 
BECs were determined from 5 𝜇L plasma samples using an AM-1 alcohol analyzer 
(Analox Instruments; Lunenburg, MA).  
3.2.3. Statistics 
 Data are presented as means +/- SEM. Ethanol intake was analyzed using 3-
factor (substrain, sex, day) mixed-design analysis of variance (ANOVA) and BEC data 
were analyzed using 2-factor (substrain, sex) ANOVA. Correlations among ethanol 
intake and BEC measurement were analyzed for each substrain. Data analysis was 
performed using SPSS 23.0 (IBM Inc., Armonk, NY) and figures were generated using 
SigmaPlot 10.0 (Systat Software Inc., San Jose, CA). Only statistically significant (p < 
.05) main effects and interactions are described in the text. 
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3.3. Results 
3.3.1. Drinking-in-the-Dark and BECs 
 ANOVA revealed a significant main effect of day [F(3, 102) = 48.78, p < .001, 
partial 𝜂" = .589], but no significant effects of sex or strain. Post-hoc pairwise 
comparisons showed that ethanol intake was significantly lowest on Day 1 and highest 
on Day 4 (Fig. 3.1). In addition, exploratory post-hoc analyses conducted on each 
individual day revealed that B6J mice displayed significantly higher ethanol intake than 
B6NJ [F(3, 34) = 6.77, p = .014, partial 𝜂" = .166] only on Day 1. 
 
Figure 3.1. Ethanol intake across days. Mean (±SEM) ethanol intake (g/kg) during 4-day 
Drinking-in-the-Dark (DID) protocol in C57BL/6J (J) and C57BL/6NJ (NJ) mice. Asterisk 
symbol indicates p < .05 for substrain comparisons on individual access days. 
 
 Following conclusion of ethanol access on Day 4, all groups showed mean BECs 
above the National Institute on Alcohol Abuse and Alcoholism (NIAAA) defined criterion 
for a “binge” episode, 80 mg/dL (NIAAA, 2004). While there were no significant effects 
of substrain or sex, females showed somewhat higher BECs than males (Table 3.1). 
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Lastly, both B6J (r = .589, n = 20, p = .006) and B6NJ (r = .581, n = 18, p = .011) 
animals demonstrated moderate, positive correlations between Day 4 ethanol intake 
and subsequent BEC (Fig 3.2). 
Table 3.1. BECs produced by DID protocol. Mean (±SEM) BECs for male (M) and 
female (F) J and NJ mice immediately following the ethanol access period on Day 4. 
BEC, blood ethanol concentrations; J, C57BL/6J; NJ, C57BL/6NJ. 
 
 
B6 Strain 
 
Sex 
 
n 
 
BEC (mg/dL) 
J F 10 118.4 ± 6.73 
J M 10 101.7 ± 5.46 
NJ F 9 113.9 ± 5.32 
NJ M 9 109.7 ± 4.92 
 
 
 
Figure 3.2. BECs vs. Day 4 ethanol intake. Means for blood ethanol concentration 
(BEC; mg/dL) plotted against means for ethanol intake (g/kg) on Day 4 of the Drinking-
in-the-Dark (DID) protocol in C57BL/6J (J) (left) and C57BL/6NJ (NJ) (right) mice. 
Correlation estimates (R2 values) are included for each respective substrain. 
 
3.4. Discussion 
 Overall, this experiment did not detect significant substrain differences in either 
binge-like drinking or BEC levels during a standard 4-day DID protocol. Both substrains 
displayed the expected increased consumption and BECs within the range of 
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seen in previous work with B6J mice (Rhodes et al., 2005; 2007). Additionally, both 
substrains demonstrated moderate, positive correlations between Day 4 ethanol intake 
and consequent BEC levels (Fig. 3.2), confirming that intake readings were indeed due 
to actual consumption and not accidental leakage from mice tampering with the drinking 
spout. In contrast to prior evidence (Rhodes et al., 2005; 2007), we did not observe 
statistically significant effects of sex on either ethanol consumption or BEC levels, 
though females showed slightly higher ethanol consumption and resultant BECs (Table 
3.1). Although the substrain x day interaction was not significant, exploratory analyses 
of potential substrain differences on individual test days indicated that B6J mice 
consumed significantly more ethanol than B6NJ mice on Day 1 only (Fig. 3.1). This 
disparity on the first access day likely reflects the substrain difference in free-choice 
ethanol consumption observed in Experiment 1. 
 Interestingly, previous data from inbred strain panels has suggested common 
genetic influences on limited-access and continuous two-bottle free-choice drinking 
(Crabbe et al., 2012; Rhodes et al., 2007). Specifically, correlations from 23 inbred 
strains indicate that the DID protocol shares about 50-70% of genetic variance in 
common with the standard two-bottle free-choice test (Crabbe et al., 2012). However, 
contrasting evidence from selected lines has emerged. HDID mice, selectively bred for 
high resultant BECs via the DID protocol, do not significantly differ in voluntary ethanol 
consumption under two-bottle free-choice conditions compared to nonselected control 
mice from the genetically heterogenous progenitor line (HS/Npt) (Crabbe et al., 2011; 
Rosenwasser et al., 2013). These data imply that genes underlying two-bottle free-
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choice drinking are at least partially distinct from those promoting binge-like drinking 
during the DID protocol. 
 Though these lines of evidence appear contradictory, the different genetic animal 
models employed to evaluate the strength of the genetic association between 
continuous two-bottle free-choice and DID drinking must be acknowledged. For 
instance, since the process of inbreeding intrinsically eliminates heterozygosity, relevant 
dominant alleles are theoretically absent within inbred strains (Crabbe et al., 2011). In 
turn, genetic dominance has been shown to influence both continuous two-bottle free-
choice (Blednov et al., 2005; 2010) and DID drinking (T. J. Phillips et al., 2010), which 
perhaps explains, in part, the disparity between data derived from inbred strain panels 
and selected lines. Additionally, there are differences in underlying mechanisms 
between the behaviors elicited by these different paradigms. Unlike continuous two-
bottle free-choice drinking, the DID protocol results in intoxicating BEC levels and 
significantly impaired motor coordination (Rhodes et al., 2007). The presence or 
absence of intoxication is potentially the reason why selection for high voluntary ethanol 
consumption under two-bottle free-choice conditions and for high BECs via the DID 
protocol is not entirely symmetrical (Crabbe et al., 2011). Indeed, estimated heritability 
of the DID trait (h2 = .10; Crabbe et al., 2009) is markedly less than that of high two-
bottle free-choice drinking (h2 = .46 - .74; Belknap et al., 1993; Wahlsten et al., 2006; 
Yoneyama et al., 2008). 
 It should also be noted that HDID mice are typically compared with a nonselected 
control line, as opposed to a line selectively-bred for low BECs following the DID 
protocol. This poses two potential issues: 1) there is a significant likelihood that some 
63 
 
animals in the genetically heterogenous stock displayed high ethanol preference 
drinking, and 2) intergenerational variance on an assay is likely to be greater in a 
genetically heterogenous stock than a selected line. Despite these potential 
disadvantages, forgoing a bidirectional selection was likely justified in this circumstance 
since most genetically heterogeneous mice already drink such small quantities (and 
therefore reach very low BECs) during the DID protocol (Crabbe et al., 2009). Also, 
since correlations between the DID protocol and the two-bottle free-choice test among 
inbred strains are strong, but not absolute, a lack of differential ethanol preference 
drinking between HDID mice and a genetically heterogenous stock is plausible. Specific 
alleles that promote high resultant BECs through the DID protocol are likely distinct in 
ethanol-preferring inbred strains and HDID mice. In fact, ethanol-related phenotypic 
correlations are typically seen much more reliable among inbred strains than in 
selectively-bred lines (Hitzemann et al., 2009; Kosobud, Bodor, & Crabbe, 1988; Metten 
et al., 1998). 
 In sum, B6J and B6NJ mice did not display significant differences in binge-like 
drinking or in ensuing BEC levels under a standard 4-day DID protocol. Thus, despite 
the aforementioned evidence for considerable overlap between the genetic influences 
on two-bottle free-choice and DID drinking, there are likely also genetic factors involved 
that contribute to one, but not the other, trait. Regarding the DID trait, it appears no 
influential mutations have arisen between B6J and B6N mice since colony separation. 
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CHAPTER 4 
EXPERIMENT 3: AFFECTIVE BEHAVIOR IN C57BL/6J AND C57BL/6NJ MICE 
DURING LONG-TERM ETHANOL ABSTINENCE 
4.1. Rationale 
 In the present experiment, male and female B6J and B6NJ mice were exposed 
either to a 7-day CIE protocol or to plain room air in inhalation chambers, and 
subsequently administered repeated well-established tests of affective behavior 
(sucrose preference test, SPT; light-dark box test, LDT; forced swim test, FST) over the 
course of four post-treatment (post-Tx) weeks. Because previous research has shown 
that genotypes characterized by higher levels of ethanol preference drinking typically 
display relatively low sensitivity to (acute) ethanol withdrawal (Hitzemann et al., 2009; 
Kosobud et al., 1988; Metten et al., 1998), we hypothesized that post-dependent B6NJ 
mice would be more likely than B6J mice to display persistent affective disturbances 
during forced abstinence. Such a result would imply that overlapping sets of genes 
contribute to both degree of voluntary ethanol intake (as measured in two-bottle free-
choice) and long-term consequences (e.g., increased anxiety- and/or depressive-like 
behavior) of dependence and subsequent abstinence. 
4.2. Materials and Methods 
4.2.1. Animals 
 Male and female B6J (M, n = 20; F, n = 20) and B6NJ (M, n = 18; F, n = 20) mice 
were shipped to the University of Maine from The Jackson Laboratory (Bar Harbor, ME). 
Mice arrived in the laboratory at approximately 6 weeks of age and were immediately 
group-housed, 5 per cage by substrain, sex, and assigned treatment (ethanol vapor vs. 
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air-control; see below), in mouse cages (32 x 20 x 14 cm). Animals were housed under 
a LD 12:12 lighting regimen (lights off at 1700) with food (Prolab RMH 3000; LabDiet, 
St. Louis, MO) and tap water available ad libitum throughout the experiment. All 
experimental procedures were approved by the University of Maine Institutional Animal 
Care and Use Committee (IACUC). 
4.2.2. Procedures 
 Mouse housing cages were initially kept within larger inhalation chambers with 
the system fan turned on and circulating plain room air for 2 weeks of acclimation. The 
inhalation chambers consisted of large Plexiglas boxes (60 x 36 x 60 cm) constructed 
according to a design provided by Dr. Howard Becker (Medical University of South 
Carolina). After acclimation, animals in the experimental group were exposed to a 7-day 
chronic-intermittent ethanol vapor exposure (CIE) protocol (see below), while controls 
were handled identically, but exposed only to plain air. Following CIE or air treatment, 
animals were single-housed in standard mouse cages (30 x 18 x 12 cm) in a light-
shielded and sound-attenuating metal cabinet equipped with a standard fluorescent bulb 
on each shelf. Six hours after termination of the final ethanol vapor exposure, all 
animals were administered the Handling-Induced Convulsions (HIC) Test. 
Subsequently, animals underwent weekly behavioral testing (see below) during a 4-
week period of (forced) abstinence, with all behavioral tests beginning at the onset of 
the dark phase. For each test week, the order of behavioral tests was as follows: (1) 
sucrose preference test (SPT), (2) light-dark box test (LDT), and (3) forced swim test 
(FST). 24 hours separated the SPT and LDT, 72 hours separated the LDT and FST, 
and 48 hours separated the final test of one week and the initial test of the successive 
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week. This order was intended to minimize the effects of repeated administration, with 
larger gaps between potentially more invasive behavioral tests. Experimental and 
control groups consisted of 9-10 animals per group for each sex/substrain; n’s for each 
group are available in Table 4.1.  
4.2.2.1. Chronic-Intermittent Ethanol Protocol 
 In the present work, a 7-day CIE protocol was employed in which ethanol vapor 
was delivered to the experimental chambers for 16 hours per day alternating with 8 
hours of plain air, with each vapor exposure period beginning at dark onset. Air-control 
animals were handled identically, but exposed only to plain air. Immediately prior to 
each vapor exposure period, CIE animals were administered a priming injection 
containing 1.6 g/kg EtOH and 68.1 mg/kg pyrazole HCl, an alcohol dehydrogenase 
inhibitor used to rapidly increase and stabilize blood ethanol concentration (BEC) (H. C. 
Becker & Hale, 1993). Pyrazole was dissolved in 20% v/v EtOH solution and injected 
i.p. in a volume of 10 mL/kg. Air-control animals were administered an identical dose of 
pyrazole in 0.9% saline solution, but without ethanol, at the same injection volume. All 
animals were weighed prior to and halfway through the 7-day CIE cycle to ensure 
appropriate injection volumes, and to monitor possible CIE-induced changes in body 
weight (see below). A mixture of EtOH vapor and air was continuously delivered during 
the exposure period. The rate of delivery remained between 10-12 L/min in order to 
ensure adequate airflow to meet the animals’ respiratory requirements. EtOH was 
vaporized using a pressurized pump to push air through a porous diffusing stone 
submerged in a 1.0-L bottle filled with 95% EtOH. To confirm EtOH vapor 
concentrations were within an appropriate range (10 to 18 mg/L) and progressively 
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increasing across days, 5.0-mL air samples were extracted from the exposure 
chambers using a 60-mL syringe and mixed with 55 mL of ambient air. The diluted 
samples were injected into a breathalyzer (Lifeloc FC-10; Wheat Ridge, CO) and the 
resultant readings compared to a standardized calibration curve of known EtOH 
concentration to determine chamber EtOH concentration. 
4.2.2.2. Measurement of Ethanol Concentrations in Tail Blood  
 BECs were measured in CIE-exposed animals immediately following the final 
treatment period. A small (approximately 10 𝜇L) blood sample was collected from the tip 
of the tail of each mouse and centrifuged for 2 minutes to separate plasma from serum. 
BECs were determined from 5 𝜇L plasma samples using an AM-1 alcohol analyzer 
(Analox Instruments; Lunenburg, MA). 
4.2.2.3. Body Weights 
 Body weights were obtained in CIE and air-control animals at the beginning of 
the CIE protocol, on Day 4 of the CIE, and at the termination of the final CIE cycle. The 
effects of CIE on body weight were evaluated by computing percent body weight 
change from the beginning to the end of the CIE protocol. 
4.2.2.4. Handling-Induced Convulsions Test 
 Animals were gently picked up by the tail, briefly held in place, and then rotated 
slowly along a 360° arc. Convulsive signs were rated by experimenters blind to 
treatment and group on a predefined scale (0-7) (Crabbe, Merrill, & Belknap, 1991; 
Metten & Crabbe, 2005), depending on the severity of the response along with the 
extent of the handling manipulation required to elicit the behavioral response. HIC 
scores typically correlate with other measures of ethanol withdrawal (Kosobud & 
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Crabbe, 1986), and are known to be sensitive to both dose and duration of chronic 
ethanol exposure (H. C. Becker & Hale, 1993; Metten et al., 2010; Metten & Crabbe, 
2005). 
4.2.2.5. Sucrose Preference Test 
 Animals were offered two-bottle, free-choice access to a 0.75% sucrose solution 
and plain water for 24 hours. Pre- and post-measurements of bottle weight (g) were 
used to obtain overall intake. Sucrose preference was determined by dividing the 
volume of sucrose solution consumed by total fluid intake. Decreases in sucrose 
preference are generally interpreted as “anhedonic behavior” (Katz, 1982), an inability 
to derive pleasure from normally pleasurable stimuli, which is one of the defining 
symptoms when diagnosing Major Depression Disorder (APA, 2013). 
4.2.2.6. Light-Dark Box Test 
 Animals were placed in a two-compartment test chamber in which one 
compartment (27 x 17 x 27 cm) is kept darkened while the other (27 x 27 x 27 cm) is 
illuminated via an overhead lamp (~550-650 lux). The compartments are separated by a 
wall with a small central opening (6 x 6 cm) through which the mouse can easily shuttle 
between the two compartments. Animals were initially placed in the dark compartment 
and were permitted to freely-move about the apparatus for 6 minutes. Behavior was 
video-recorded and the following parameters were extracted: (1) percentage of time 
spent in the light compartment, (2) latency to first entry to the light compartment, and (3) 
the total number of transitions between compartments. Less time spent in, and longer 
latencies to initially enter, the light compartment are interpreted as anxiety-like behavior 
based in part on extensive pharmacological evidence that anxiolytic drugs increase the 
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percentage of time an animal spends in the light compartment (Bourin & Hascoët, 
2003). The number of transitions between compartments is used as an assay of general 
locomotor activity in the test environment, and is typically reduced by anxiogenic 
treatments including ethanol withdrawal (Kliethermes, 2005). 
4.2.2.7. Forced Swim Test 
 Animals were placed in a clean, glass cylinder (20 cm diameter, 30 cm tall) filled 
with tap water (maintained at a temperature of 23-25°C) to a depth of 15 cm for 6 
minutes. Behavior was video-recorded and the percentage of time spent actively 
swimming (as opposed to passively floating) was determined via ANY-maze software 
(Stoelting Co., Wood Dale, IL). After each session, animals were removed from the 
water, lightly dried via paper towel, and individually kept in a standard cage positioned 
under a red light lamp for 10 minutes (to ensure adequate drying) before returning to 
their respective home cage. Water in the cylinder was emptied and replaced with fresh 
water after each session. This test is thought to reflect the balance between active and 
passive coping strategies in response to a minor stressor (Commons, Cholanians, 
Babb, & Ehlinger, 2017); swimming is interpreted as active coping, while floating is 
interpreted as passive coping (i.e., depressive-like behavior). There is an abundance of 
pharmacological evidence that antidepressant administration increases the percentage 
of time spent actively swimming (Petit-Demouliere, Chenu, & Bourin, 2005; Porsolt, 
Bertin, Blavet, Deniel, & Jalfre, 1979). 
4.2.2.8. Statistics 
 Data are presented as means +/- SEM. Behavioral data were analyzed using 4-
factor (treatment, substrain, sex, post-Tx day) mixed-design analysis of variance 
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(ANOVA), followed where appropriate by separate 3- or 2-factor ANOVAs with 
subsequent Bonferroni-corrected post-hoc tests. Initial body weight, percent body 
weight change, and HIC test data were analyzed using 3-factor (treatment, substrain, 
sex) ANOVA, while BECs were analyzed in ethanol-exposed animals only using 2-factor 
(substrain, sex) ANOVA. Data analysis was performed using SPSS 23.0 (IBM Inc., 
Armonk, NY) and figures were generated using SigmaPlot 10.0 (Systat Software Inc., 
San Jose, CA). Only statistically significant (p < .05) main effects and interactions are 
described in the text, and while exact p-values are not given for pairwise comparisons, 
all pairwise tests mentioned were significant at p < .05. 
4.3. Results 
4.3.1. Body Weights, BECs, and HIC Test 
 Prior to treatment, males weighed significantly more than females [F(1, 70) = 
339.84, p < .001, partial 𝜂" = .829] and B6J mice weighed significantly more than B6NJ 
[F(1, 101) = 22.40, p = .046, partial 𝜂" = .056], but there were no significant differences 
between assigned treatment (Table 4.1). 
Table 4.1. Changes in body weight across CIE protocol. Mean (±SEM) body weight 
(BW) in male (M) and female (F) J and NJ mice immediately prior to and following CIE 
or air-control (CON) treatment and percent change in body weight during treatment. 
CIE, chronic-intermittent ethanol; J, C57BL/6J; NJ, C57BL/6NJ. 
 
B6 Substrain Sex Treatment n Pre-Tx BW (g) Post-Tx BW (g) % BW change 
J F CON 10 18.3 ± 0.45 19.1 ± 0.36 +4.13 ± 0.89 
J F CIE 10 19.1 ± 0.57 19.3 ± 0.55 +1.02 ± 0.98 
J M CON 10 24.2 ± 0.30 24.7 ± 0.35 +2.15 ± 0.70 
J M CIE 10 25.3 ± 0.25 25.3 ± 0.30 +0.25 ± 0.78 
NJ F CON 10 18.7 ± 0.32 19.8 ± 0.33 +6.21 ± 1.60 
NJ F CIE 10 18.6 ± 0.32 18.8 ± 0.34 +1.22 ± 1.15 
NJ M CON 9 23.6 ± 0.57 24.3 ± 0.52 +2.87 ± 1.15 
NJ M CIE 9 23.5 ± 0.49 23.5 ± 0.53 -0.10 ± 0.89 
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 Expressed as percent change from pre-Tx weight, ethanol-exposed animals 
gained significantly less weight than air-controls [F(1, 70) = 18.88, p < .001, partial 𝜂" = 
.212] and males gained significantly less weight than females [F(1, 70) = 6.16, p = .015, 
partial 𝜂" = .081] over the course of treatment. All groups showed mean BECs well 
above the threshold for intoxication, and while there were no significant effects of sex or 
substrain, females showed somewhat higher BECs than males (Table 4.2). Lastly, 
ethanol-exposed animals exhibited significantly higher HIC scores than air-controls [F(1, 
70) = 14.40, p < .001, partial 𝜂" = .171] six hours after termination of the final treatment 
period (Fig. 4.1), but there were no significant effects of substrain or sex. 
Table 4.2. BECs produced by CIE protocol. Mean (±SEM) BECs for ethanol-exposed 
male and female J and NJ mice immediately following the 7-day CIE protocol. BEC, 
blood ethanol concentrations; other abbreviations as in Table 3.1. 
 
B6 Substrain Sex Treatment n BEC (mg/dL) 
J F CIE 10 155.7 ± 6.24 
J M CIE 10 150.0 ± 8.74 
NJ F CIE 10 155.7 ± 11.81 
NJ M CIE 9 142.1 ± 8.67 
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Figure 4.1. Handling-induced convulsions during acute withdrawal. Mean (±SEM) 
handling-induced convulsions (HICs) scores six hours following 7-day chronic-
intermittent ethanol (EtOH) and control (Air) treatments in C57BL/6J (J) and C57BL/6NJ 
(NJ) mice. 
 
4.3.2. Sucrose Preference Test 
 ANOVA revealed significant main effects of treatment [F(1, 70) = 7.72, p = .007, 
partial 𝜂" = .099] and post-Tx day [F(3, 210) = 4.52, p = .004, partial 𝜂" = .061], as well 
as significant treatment x post-Tx day [F(3, 210) = 7.86, p < .001, partial 𝜂" = .101] and 
substrain x treatment x sex [F(1, 70) = 4.41, p = .039, partial 𝜂" = .059] interactions (Fig. 
4.2). Ethanol-exposed animals exhibited significantly lower sucrose preference than air-
exposed controls overall, and post-hoc analysist showed that this effect was significant 
on post-Tx days 8, 15, and 22, but not post-Tx day 1. Sucrose preference was 
significantly lower on post-Tx day 15 than on post-Tx days 8 and 22, but not on post-Tx 
day 1. To explore the interaction involving sex, separate substrain x treatment ANOVAs 
were performed in males and females for each individual test day (Fig. 4.2). In females, 
a main effect of treatment was present on post-Tx days 1, 15, and 22; however, 
ethanol-exposed animals displayed significantly higher sucrose preference on post-Tx 
day 1, but significantly lower sucrose preference on post-Tx days 15 and 22. In males, 
sucrose preference was significantly higher in B6J mice on post-Tx day 15 and 
significantly lower in ethanol-exposed mice on post-Tx day 22. 
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Figure 4.2. Sucrose preference during post-Tx period. Mean (±SEM) sucrose 
preference following 7-day chronic-intermittent ethanol (EtOH) and control (Air) 
treatments in all animals (top), female only (middle), and male only (bottom) C57BL/6J 
(J) and C57BL/6NJ (NJ) mice. 
 
4.3.3. Light-Dark Box Test 
4.3.3.1. Percentage of Time in Light 
 ANOVA revealed significant main effects of substrain [F(1, 70) = 8.97, p = .004, 
partial 𝜂" = .114] and post-Tx day [F(3, 210) = 23.03, p < .001, partial 𝜂" = .248], as well 
as a significant post-Tx day x sex interaction [F(3, 210) = 3.18, p = .025, partial 𝜂" = 
.043], but no significant effects involving treatment (Fig. 4.3). B6J mice spent a 
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significantly greater percentage of time in light than B6NJ. Females displayed a 
significantly lower percentage of time in light on post-Tx day 3 than all other test days, 
while males showed a significantly lower percentage of time in light on post-Tx days 3 
and 24 than on other test days (Fig. 4.3). 
 
Figure 4.3. Percentage of time in light during post-Tx period. Mean (±SEM) percentage 
of time spent in light following 7-day chronic-intermittent ethanol (EtOH) and control (Air) 
treatments in all animals (top), female only (middle), and male only (bottom) C57BL/6J 
(J) and C57BL/6NJ (NJ) mice. Post-Tx days with no shared letters are significantly 
different (p < .05) from one another. 
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4.3.3.2. Latency to Enter Light 
 ANOVA revealed significant main effects of substrain [F(1, 70) = 19.08, p < .001, 
partial 𝜂" = .214] and post-Tx day [F(3, 210) = 11.23, p < .001, partial 𝜂" = .138], as well 
as significant substrain x post-Tx day [F(3, 210) = 7.32, p < .001, partial 𝜂" = .095] and 
substrain x treatment x sex [F(1, 70) = 7.44, p = .008, partial 𝜂" = .096] interactions (Fig. 
4.4). B6NJ animals exhibited significantly longer latencies to enter the light than B6J 
animals overall, and post-hoc tests showed that this effect was significant on post-Tx 
days 3 and 10. Latency to enter light was significantly longer on post-Tx day 3 than all 
other test days. To investigate the interaction involving sex, separate substrain x 
treatment ANOVAs were performed in males and females (Fig. 4.4). While a significant 
main effect of substrain was present in both sexes [Females: F(1, 136) = 5.52, p = .024, 
partial 𝜂" = .133; Males: F(1, 34) = 16.01, p < .001, partial 𝜂" = .320], a significant 
substrain x treatment interaction was observed only in males [F(1, 34) = 5.33, p = .027, 
partial 𝜂" = .135]. In both sexes, B6NJ animals exhibited significantly longer latencies 
than B6J animals, but, among males, only B6NJ animals showed longer latencies after 
ethanol than after air treatment.  
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Figure 4.4. Latency to light during post-Tx period. Mean (±SEM) latency of first 
transition to light following 7-day chronic-intermittent ethanol (EtOH) and control (Air) 
treatments in all animals (top), female only (middle), and male only (bottom) C57BL/6J 
(J) and C57BL/6NJ (NJ) mice. 
 
4.3.3.2. Total Transitions 
 ANOVA revealed significant main effects of substrain [F(1, 70) = 106.99, p < 
.001, partial 𝜂" = .605], sex [F(1, 70) = 11.76, p = .001, partial 𝜂" = .144], and post-Tx 
day [F(3, 210) = 4.57, p = .004, partial 𝜂" = .061], but no treatment effects (Fig 4.5). B6J 
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mice and females displayed significantly greater total transitions than B6NJ mice and 
males, respectively. Total transitions were significantly lower on post-Tx day 3 than 
post-Tx day 10, but no other significant differences were present between test days. 
 
Figure 4.5. Total transitions during post-Tx period. Mean (±SEM) total transitions 
following 7-day chronic-intermittent ethanol (EtOH) and control (Air) treatments in 
C57BL/6J (J) and C57BL/6NJ (NJ) mice. 
 
4.3.4. Forced Swim Test 
 ANOVA revealed significant main effects of substrain [F(1, 70) = 8.20, p = .006, 
partial 𝜂" = .105], treatment [F(1, 70) = 4.79, p = .032, partial 𝜂" = .064], and post-Tx 
day [F(3, 210) = 70.58, p < .001, partial 𝜂" = .502], as well as a significant substrain x 
treatment x post-Tx day interaction [F(3, 210) = 3.50, p = .016, partial 𝜂" = .026], but no 
significant effects involving sex (Fig. 4.6). Overall, B6J and ethanol-exposed mice 
displayed significantly higher immobility than B6NJ and air-controls, respectively, while 
immobility was significantly lower on post-Tx day 6 than all other test days. To examine 
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the interaction involving post-Tx day, separate substrain x treatment ANOVAs were 
performed for individual test days. Significant main effects of substrain were present on 
post-Tx days 13 [F(1, 70) = 9.33, p = .003, partial 𝜂" = .112] and 27 [F(1, 70) = 6.14, p = 
.015, partial 𝜂" = .077], significant main effects of treatment were seen on post-Tx days 
13 [F(1, 70) = 5.85, p = .018, partial 𝜂" = .073] and 20 [F(1, 70) = 4.41, p = .039, partial 𝜂" = .056], and a significant substrain x treatment interaction was noted on post-Tx day 
20 [F(1, 70) = 4.24, p = .047, partial 𝜂" = .052]. B6J mice displayed significantly higher 
immobility than B6NJ mice on post-Tx days 13 and 27. Ethanol-exposed mice displayed 
significantly higher immobility than air-controls on post-Tx days 13 and 20; however, on 
post-Tx day 20, this effect was only present in B6NJ mice. 
 
Figure 4.6. Immobility during post-Tx period. Mean (±SEM) time spent immobile (s) 
following 7-day chronic-intermittent ethanol (EtOH) and control (Air) treatments in 
C57BL/6J (J) and C57BL/6NJ (NJ) mice. Asterisk symbol indicates p < .05 for treatment 
pairwise comparisons. 
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4.4. Discussion 
 Overall, this experiment detected significant test-dependent effects of CIE 
treatment, substrain, sex, and post-Tx day, but detected few substrain differences in the 
expression of affective disturbances during long-term forced abstinence (i.e., substrain x 
treatment interactions). Thus, we found little evidence for substrain differences in the 
affective consequences of ethanol withdrawal. Nonetheless, several other effects 
produced useful insights that warrant further discussion. 
 As expected, ethanol-exposed mice reached pharmacologically-relevant BECs 
(~150 mg/dL) and correspondingly displayed significantly higher HIC scores than air-
controls (Fig. 4.1), thus confirming the ability of our CIE vapor exposure protocol to 
induce dependence and withdrawal. Interestingly, despite high BEC levels, effects of 
CIE treatment were more reliably seen on assays for depressive-like (SPT and FST), 
than anxiety-like (LDT), behavior. These findings support two emerging generalizations 
within the literature: 1) induction of physical dependence, specifically through high dose 
forced ethanol administration paradigms, does not reliably result in global affective 
symptoms, and 2) mice, unlike rats, display more consistent manifestation of 
depressive- versus anxiety-like behaviors during ethanol withdrawal (Holleran & Winder, 
2017). 
 While the literature is complex, the emergence of affective disturbances in post-
dependent animals has been shown to follow distinct temporal trajectories which 
depend on several factors, including the specific ethanol-administration protocols and 
behavioral assays utilized (Heilig et al., 2010; Kliethermes, 2005). While significant 
effects of post-Tx day were seen throughout all measures of each behavioral assay, in 
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the absence of post-Tx day x CIE treatment interactions, effects of post-Tx day are 
unlikely to be related to ethanol exposure per se. Therefore, we focus our discussion on 
significant post-Tx day x treatment interactions. In the SPT, ethanol-exposed mice 
showed significantly greater sucrose preference on post-Tx day 1 (albeit only in 
females), but exhibited lower sucrose preference (suggestive of anhedonia) on each 
subsequent test day (post-Tx days 8, 15, and 22). This reversal in the effects of CIE 
between post-Tx days 1 and 8 illustrates the complex temporal dynamics of affective 
processing in post-dependent animals (Heilig et al., 2010; Holleran & Winder, 2017). 
 Similarly, in the FST, ethanol-exposed mice exhibited greater depressive-like 
behavior (i.e., greater time spent immobile) overall, and specifically on post-Tx days 13 
and 20. Together, the SPT and FST data suggest that CIE vapor exposure induced a 
delayed and sustained display of behavioral depression, which is consistent with 
previous work using either long-term free-choice drinking or maintenance on ethanol 
liquid diet to induce dependence (Gong et al., 2017; Holleran et al., 2016; Kim et al., 
2017; Pang et al., 2013; Roni & Rahman, 2017; Stevenson et al., 2009). Thus, our data 
provide novel evidence for the ability of CIE vapor exposure to induce delayed and 
sustained emergence of depressive-like behavior during long-term forced abstinence. 
 As previously mentioned, overall effects of CIE treatment were not consistently 
observed in the LDT. Regarding the three dependent variables measured in the LDT, 
only latency to the first transition to light revealed any effect of CIE treatment. Prior work 
suggests that anxiety-like behaviors are most often observed during acute withdrawal 
(Finn et al., 2000; Gong et al., 2017; Kash et al., 2009; Kliethermes et al., 2004; Perez & 
De Biasi, 2015; Pleil et al., 2015; Rose et al., 2016), but begin to wane during early 
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abstinence and are generally absent during protracted abstinence (J. A. J. Becker et al., 
2017; Fukushiro et al., 2012; Holleran et al., 2016; Lee et al., 2015; 2017; Pang et al., 
2013). Assays for anxiety-like behavior, such as the LDT, are typically based on the 
animal’s innate tendency to balance exposure to light (“dangerous”) and dark (“safe”) 
environments, and are widely considered to provide a valid model for defensive or risk-
assessment behavior (Hascoët, Bourin, & Nic Dhonnchadha, 2001). However, there is 
still some debate regarding the possibility that “non-anxious” behaviors, such as overall 
locomotor activity, may confound results obtained from these types of assays. 
Moreover, some evidence suggests that general locomotion and anxiety-related 
behaviors are negatively correlated and difficult to dissociate (Kliethermes, 2005; Milner 
& Crabbe, 2008). Thus, in line with previous research, we found consistent findings 
between the arguably confounded variables of total time spent in light and total 
transitions, the latter of which usually serves as a marker of general locomotor activity 
(Kliethermes, 2005). In contrast to the majority of previous work, our data reveal a 
significant effect of CIE treatment on the latency to the first transition, but not for overall 
time spent in the light compartment; however, since the CIE effect is embedded within a 
3-way interaction that also involves both substrain and sex, it will be further discussed 
below. 
 B6J and B6NJ mice displayed significant differences more consistently in tests of 
anxiety-like behavior than depressive-like behavior. For example, overall, B6J mice 
exhibited a significantly higher percentage of time in the light compartment (Fig. 4.3) 
and greater number of transitions (Fig. 4.5) than B6NJ mice, suggesting that B6J are 
genetically less anxious than B6NJ. Since these effects were observed in the absence 
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of interactions with CIE treatment, they appear to represent the differential segregation 
of anxiety-related alleles in the two substrains. However, a substrain x treatment x sex 
interaction revealed that ethanol-exposed B6NJ animals exhibited significantly longer 
latencies than ethanol-exposed B6J animals, an interaction driven largely by substrain 
differences in male mice. Although this is clear evidence of a substrain difference in 
abstinence-induced anxiety-like behavior (at least in males), such an interaction was 
seen only for this single dependent variable of the LDT. 
 In our measures of depressive-like behavior, effects of substrain occurred in 
complex interactions with CIE treatment, post-Tx day (SPT, FST), and sex (SPT). In the 
SPT, substrain differences (B6J > B6NJ) were seen only in males and were significant 
only on post-Tx day 15, but the effects of CIE treatment were driven largely by females 
(Fig. 4.6). In contrast, the FST data revealed a similar initial emergence of depressive-
like behavior (during early abstinence) in ethanol-exposed mice of both substrains, but a 
suggestive substrain difference in the persistence of depressive-like behavior over time. 
Thus, ethanol-exposed mice displayed significantly higher immobility than air-controls 
on both post-Tx days 13 and 20, but on post-Tx day 20 this effect was only present in 
B6NJ mice, suggesting that CIE treatment may induce somewhat longer lasting 
behavioral depression in B6NJ mice than B6J mice. Nevertheless, since this was 
observed only in the FST, and not the SPT, we are unable to infer concrete conclusions 
regarding the possible substrain differences in abstinence-induced depressive-like 
behavior. 
Historically, consistent negative correlative relationships have been seen 
between ethanol preference drinking and HIC withdrawal severity among inbred strains 
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(Metten et al., 1998; 2014). At the extremes, B6J mice exhibit high ethanol preference 
drinking and low HIC severity, whereas D2J mice show low ethanol preference drinking 
and high HIC severity (Belknap et al., 1993; Metten et al., 1998; 2010; Metten & 
Crabbe, 2005; Yoneyama et al., 2008). These variables have also been postulated to 
be predictive of the manifestation of anxiety- and/or depressive-like behavior during 
forced ethanol abstinence. For instance, 72 hours following termination of a 4-day CIE 
vapor exposure, D2J mice showed greater anxiety-like behavior on the LDT than B6J, 
compared to their respective air-exposed controls (McCool & Chappell, 2015). Similarly, 
C3H mice, who display intermediate levels of ethanol preference drinking and HIC 
withdrawal severity demonstrated more dramatic and sustained hypolocomotion 
following 3-cycle CIE exposure than did B6J mice (Logan et al., 2012). Intriguingly, our 
data demonstrates that similar associations do not appear to manifest between B6J and 
B6NJ substrains. Despite displaying significantly different levels of ethanol preference 
drinking (Experiment 1), B6J and B6NJ mice do not differ in HIC severity, nor, as we 
have now shown, in abstinence-induced anxiety- or depressive-like behavior.  
 Perhaps the principal finding of this study, however, is that despite significant 
effects of both substrain and CIE treatment in various behavioral assays, there was little 
overall evidence for substrain x CIE treatment interactions. For some variables (SPT, 
FST), such findings were embedded within complex interactions among other factors, 
and a clear substrain x CIE treatment interaction was seen only for one of three relevant 
dependent variables in the LDT, and only in males. Together, these observations 
suggest that observed differences in ethanol preference drinking in B6J and B6NJ mice 
(Experiment 1) are generally not associated with substrain differences in abstinence-
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induced affective disruption. Thus, it appears no mutations influential for abstinence-
induced affective disruption have arisen in either B6J or B6N mice since colony 
separation. 
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CHAPTER 5 
GENERAL DISCUSSION 
 The present set of experiments establish considerable substrain differences 
between B6J and B6NJ mice in two-bottle free-choice ethanol drinking and wheel-
running, but not in binge-like drinking or abstinence-induced affective disruption. 
Moreover, our results show that allelic variation in Cyfip2 contributes substantially to 
substrain differences between B6J and B6NJ mice in two-bottle free-choice ethanol 
drinking; however, since substrain differences were completely reversed by allelic 
substitution in males, but not females, it’s likely that sex-specific contributions from other 
polymorphisms play a role in moderating these effects. In contrast, Cyfip2 appears to 
have a more modest influence on substrain differences in wheel-running, as differences 
were only partially reversed in males and completely unaffected in females. Future 
research will be necessary to identify possible gene-gene interactions and genetic 
background effects modulating the effects of Cyfip2 on two-bottle free-choice ethanol 
drinking. 
 Historically, inbred strain panels have served as an integral approach for the 
discovery and characterization of ethanol-related phenotypic correlations (Crabbe et al., 
2010; Metten et al., 1998). Researchers have attempted to derive concrete relationships 
between the observed level of two-bottle free-choice ethanol drinking, the most 
extensively studied ethanol-related behavior, and performance on various other ethanol-
related assays in order to estimate the degree of common genetic variance underlying 
two (or more) distinct phenotypes (Crabbe et al., 1990; 2010; 2012). Furthermore, the 
proliferation of gene mapping efforts, and the fact that gene mapping data are 
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cumulative, has facilitated the comparison of genetic loci influencing multiple traits 
(Crabbe, Belknap, & Buck, 1994). Though these methodologies have afforded 
substantial insight regarding potential overlap of gene sets contributing to diverse 
ethanol-related phenotypes, our utilization of B6 substrains in the present set of 
experiments provides novel observations that sometimes stand in contrast to certain 
prior conclusions. 
 For example, data from inbred strain panels suggests a significant amount of 
genetic overlap between two-bottle free-choice and DID drinking (Crabbe et al., 2012; 
Rhodes et al., 2007). Nevertheless, despite demonstrating considerable differences in 
two-bottle free-choice drinking (Experiment 1), B6J and B6NJ mice did not significantly 
differ in DID drinking (Experiment 2). Moreover, though Cyfip2 allelic variation 
influenced the observed substrain differences in two-bottle free-choice ethanol drinking, 
it likely plays no role in modulation of binge-like drinking. These findings provide 
evidence that certain genes, such as Cyfip2, can selectively contribute to a distinct 
ethanol-related phenotype. 
 Another approach (beyond inbred strain panels) for revealing whether 
overlapping gene sets contribute to multiple traits is the examination of selectively-bred 
lines for a potentially related phenotype distinct from the selection phenotype (Crabbe et 
al., 1990). Research using this approach has established that ethanol-related 
phenotypic correlations are typically seen much more reliably among inbred strains than 
in selectively-bred lines (Hitzemann et al., 2009; Kosobud et al., 1988; Metten et al., 
1998). Interestingly, evidence from a mouse line selectively bred for high resultant 
BECs in the DID protocol (i.e., HDID mice) supports our findings from B6J and B6NJ 
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mice, in that HDID mice do not significantly differ in two-bottle free-choice ethanol 
drinking compared to nonselected control mice from a genetically heterogenous 
progenitor line (HS/Npt) (Crabbe et al., 2011; Rosenwasser et al., 2013). In sum, then, 
while partially overlapping gene sets contribute to both two-bottle free-choice and binge-
like DID drinking among inbred strains, evidence from selectively-bred HDID mice and 
B6 substrains show that the genes underlying two-bottle free-choice drinking are at 
least partially distinct from those promoting binge-like drinking in the DID protocol. 
 Acute withdrawal severity – as typically measured by HIC scores – is another 
well-studied ethanol-related phenotype, second only to two-bottle free-choice drinking. 
Accordingly, several analyses have suggested an inverse genetic relationship between 
two-bottle free-choice ethanol drinking and HIC severity (Hitzemann et al., 2009; Metten 
et al., 1998). For example, B6J mice consistently exhibit the highest levels of voluntary 
ethanol drinking during two-bottle free-choice access and the lowest HIC severity in 
response to a 72-hour chronic vapor exposure (Belknap et al., 1993; Metten & Crabbe, 
2005; Yoneyama et al., 2008). Interestingly, we found that B6J and B6NJ mice did not 
significantly differ in HIC severity in response to a 7-day CIE vapor exposure paradigm 
(Experiment 3), despite demonstrating considerable differences in two-bottle free-choice 
drinking (Experiment 1). Again, while Cyfip2 allelic variation contributes to differences in 
two-bottle free-choice ethanol drinking between B6J and B6NJ mice, Cyfip2 appears to 
exerts no significant influence on withdrawal-related HIC severity. As above, however, 
while our data contrast with prior work involving inbred strain panels, our findings are 
consistent with evidence from selectively-bred lines, as WSP and WSR mice, 
selectively-bred for divergent HIC severity, do not significantly differ in two-bottle free-
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choice ethanol drinking (Crabbe et al., 2013; Rosenwasser et al., 2013). Thus, while the 
genes underlying two-bottle free-choice drinking and acute withdrawal severity appear 
to overlap among inbred strain panels, studies with selected lines and B6 substrains 
show that these gene sets are at least partially distinct. 
 Compared to the aforementioned ethanol-related phenotypes, abstinence-
induced anxiety- and/or depressive-like behavior has been less extensively 
characterized, especially from a genetic standpoint. Thus, evidence for specific genetic 
correlations between two-bottle free-choice ethanol drinking and abstinence-induced 
affective disturbances is relatively sparse and existing data are somewhat inconsistent. 
For example, some evidence suggests that strains which exhibit low ethanol preference 
drinking will show increased susceptibility to abstinence-induced affective disruptions. 
During acute withdrawal, D2J mice, a strain characterized by low voluntary ethanol 
consumption, showed greater anxiety-like behavior on the LDT than B6J, a strain which 
typically exhibits high voluntary ethanol consumption (McCool & Chappell, 2015). 
Nonetheless, another study, which examined anxiety-like behavior during acute 
withdrawal, found that both D2J and B6J mice exhibited similar levels of anxiety-like 
behavior on the EPM (Finn et al., 2000). Furthermore, during early abstinence, both D2J 
and B6J mice exhibited significant anxiety-like behavior on the MBT (Sidhu et al., 2018). 
In terms of abstinence-induced depressive-like behavior, prior evidence indicates that 
C3H mice, who usually exhibit intermediate levels of voluntary ethanol consumption, 
demonstrate sustained hypolocomotion up to 30 days, whereas B6J mice display 
hypolocomotion for only 7 days (Logan et al., 2012). Interestingly, in our data, we found 
little evidence for differences in abstinence-induced anxiety- or depressive-like behavior 
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between B6J and B6NJ mice (Experiment 3). Although more work is needed, the 
current available evidence seems to indicate that voluntary ethanol intake (as measured 
in two-bottle free-choice) and long-term consequences (e.g., increased anxiety- and/or 
depressive-like behavior) of dependence and subsequent abstinence are dependent on 
largely non-overlapping gene networks. 
Recently, our laboratory has examined the potential association between acute 
ethanol withdrawal severity (i.e., HIC severity) and long-term abstinence-induced 
affective disruption (i.e., anxiety- and/or depressive-like behavior) in selectively-bred 
WSP-2 and WSR-2 mice (Hartmann et al., 2019). To date, little is known regarding 
possible linkages between the acute and long-term sequelae of ethanol dependence 
(Heilig et al., 2010). We found no significant differences in abstinence-induced anxiety- 
and/or depressive-like behavior between WSP-2 and WSR-2 mice, implying that acute 
and long-term consequences of ethanol withdrawal appear to be dependent on largely 
non-overlapping gene networks. Interestingly, in Experiment 3, we observed no 
significant differences in HIC severity between B6J and B6NJ mice in response to a 7-
day CIE vapor exposure protocol, yet, correspondingly, found little evidence for 
substrain differences in abstinence-induced affective disruption. These contrasting 
findings illustrate the need for further work in defining this potential relationship between 
these ethanol-related phenotypes. 
Although not evaluated in the current set of experiments, it we would interesting 
to examine whether B6J and B6NJ mice differ in dependence-induced escalation of 
voluntary ethanol intake. As indicated previously, such work almost exclusively utilizes 
B6J mice (H. C. Becker & Lopez, 2004; Finn et al., 2007; W. C. Griffin, Lopez, & 
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Becker, 2009a; W. C. Griffin, Lopez, Yanke, Middaugh, & Becker, 2009b; Lopez et al., 
2012; 2014; Lopez & Becker, 2005), due to their tendency to voluntarily consume 
greater quantities of ethanol, relative to other inbred strains. Intriguingly, previous data 
from selectively-bred lines do not suggest substantial common genetic influence on DID 
and dependence-induced escalation of voluntary ethanol intake (Crabbe et al., 2012). 
Therefore, since we found that B6J and B6NJ mice did not differ in DID drinking 
(Experiment 2), it’s plausible that significant substrain differences would be observed in 
dependence-induced escalation of voluntary ethanol intake. 
Overall, utilization of B6 substrains allowed discovery of an uncommon instance 
where two genetically distinct populations (albeit more genetically similar compared to 
two distinct inbred strains) substantially differed in two-bottle free-choice ethanol 
drinking but not binge-like drinking, HIC severity, or abstinence-induced affective 
disruption. B6 substrains allow a surprisingly robust balance between genetic similarity 
and diversity which can produce considerable phenotypic differences. Since genetic 
variants that underlie B6 substrain differences are likely to frequently be different from 
variants identified in inbred strain panels, we posit use of such experimental framework 
as a powerful approach for uncovering novel genetic contributions and insights of 
various ethanol-related phenotypes. 
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